Ранг,Слово,Абсолютная частота,Относительная частота,Нормализованный ранг,Нормализированная частота
1,na,59,0.02732746641963872,0.0,-3.599862986609088
2,patients,45,0.020842982862436313,0.6931471805599453,-3.8707379407444877
3,igg4,40,0.018527095877721167,1.0986122886681098,-3.988520976400871
4,md,35,0.01621120889300602,1.3862943611198906,-4.122052369025393
5,levels,20,0.009263547938860583,1.6094379124341003,-4.681668156960816
6,igg4-rsd,18,0.008337193144974525,1.791759469228055,-4.787028672618643
7,phd,14,0.006484483557202408,1.9459101490553132,-5.0383431008995485
8,plasma,13,0.006021306160259379,2.0794415416798357,-5.112451073053271
9,infiltration,13,0.006021306160259379,2.1972245773362196,-5.112451073053271
10,sg,13,0.006021306160259379,2.302585092994046,-5.112451073053271
11,14,12,0.00555812876331635,2.3978952727983707,-5.1924937807268075
12,25,11,0.005094951366373321,2.4849066497880004,-5.279505157716437
13,1,11,0.005094951366373321,2.5649493574615367,-5.279505157716437
14,gl,11,0.005094951366373321,2.6390573296152584,-5.279505157716437
15,patient,11,0.005094951366373321,2.70805020110221,-5.279505157716437
16,ln,11,0.005094951366373321,2.772588722239781,-5.279505157716437
17,blood,10,0.004631773969430292,2.833213344056216,-5.3748153375207615
18,organ,10,0.004631773969430292,2.8903717578961645,-5.3748153375207615
19,elevated,10,0.004631773969430292,2.9444389791664403,-5.3748153375207615
20,fibrosis,10,0.004631773969430292,2.995732273553991,-5.3748153375207615
21,312,10,0.004631773969430292,3.044522437723423,-5.3748153375207615
22,medicine,9,0.0041685965724872626,3.091042453358316,-5.480175853178588
23,serum,9,0.0041685965724872626,3.1354942159291497,-5.480175853178588
24,6,9,0.0041685965724872626,3.1780538303479458,-5.480175853178588
25,pancreas,9,0.0041685965724872626,3.2188758248682006,-5.480175853178588
26,kidney,9,0.0041685965724872626,3.258096538021482,-5.480175853178588
27,volume91number1january2012,8,0.0037054191755442334,3.295836866004329,-5.597958888834971
28,wwwmd-journalcom,8,0.0037054191755442334,3.332204510175204,-5.597958888834971
29,2,8,0.0037054191755442334,3.367295829986474,-5.597958888834971
30,3,8,0.0037054191755442334,3.4011973816621555,-5.597958888834971
31,cells,8,0.0037054191755442334,3.4339872044851463,-5.597958888834971
32,findings,8,0.0037054191755442334,3.4657359027997265,-5.597958888834971
33,presented,8,0.0037054191755442334,3.4965075614664802,-5.597958888834971
34,disease,7,0.003242241778601204,3.5263605246161616,-5.731490281459494
35,histologic,7,0.003242241778601204,3.5553480614894135,-5.731490281459494
36,polyclonal,7,0.003242241778601204,3.58351893845611,-5.731490281459494
37,cell,7,0.003242241778601204,3.6109179126442243,-5.731490281459494
38,yes,7,0.003242241778601204,3.6375861597263857,-5.731490281459494
39,2012lippincottwilliamswilkins,7,0.003242241778601204,3.6635616461296463,-5.731490281459494
40,n,7,0.003242241778601204,3.6888794541139363,-5.731490281459494
41,12,7,0.003242241778601204,3.713572066704308,-5.731490281459494
42,fh,7,0.003242241778601204,3.7376696182833684,-5.731490281459494
43,reported,6,0.002779064381658175,3.7612001156935624,-5.885640961286752
44,igg,6,0.002779064381658175,3.784189633918261,-5.885640961286752
45,sclerosing,6,0.002779064381658175,3.8066624897703196,-5.885640961286752
46,clinical,6,0.002779064381658175,3.828641396489095,-5.885640961286752
47,staining,6,0.002779064381658175,3.8501476017100584,-5.885640961286752
48,igg3,6,0.002779064381658175,3.871201010907891,-5.885640961286752
49,9,6,0.002779064381658175,3.8918202981106265,-5.885640961286752
50,range,6,0.002779064381658175,3.912023005428146,-5.885640961286752
51,frequent,6,0.002779064381658175,3.9318256327243257,-5.885640961286752
52,showed,6,0.002779064381658175,3.9512437185814275,-5.885640961286752
53,french,5,0.002315886984715146,3.970291913552122,-6.067962518080707
54,registry,5,0.002315886984715146,3.9889840465642745,-6.067962518080707
55,reports,5,0.002315886984715146,4.007333185232471,-6.067962518080707
56,laboratory,5,0.002315886984715146,4.02535169073515,-6.067962518080707
57,inflammatory,5,0.002315886984715146,4.04305126783455,-6.067962518080707
58,diagnosis,5,0.002315886984715146,4.060443010546419,-6.067962518080707
59,criteria,5,0.002315886984715146,4.07753744390572,-6.067962518080707
60,involvement,5,0.002315886984715146,4.0943445622221,-6.067962518080707
61,9135,5,0.002315886984715146,4.110873864173311,-6.067962518080707
62,lymphocytic,5,0.002315886984715146,4.127134385045092,-6.067962518080707
63,28,5,0.002315886984715146,4.143134726391533,-6.067962518080707
64,8,5,0.002315886984715146,4.1588830833596715,-6.067962518080707
65,rpf,5,0.002315886984715146,4.174387269895637,-6.067962518080707
66,4,5,0.002315886984715146,4.189654742026425,-6.067962518080707
67,5,5,0.002315886984715146,4.204692619390966,-6.067962518080707
68,10,5,0.002315886984715146,4.219507705176107,-6.067962518080707
69,18,5,0.002315886984715146,4.23410650459726,-6.067962518080707
70,liver,5,0.002315886984715146,4.248495242049359,-6.067962518080707
71,010,5,0.002315886984715146,4.2626798770413155,-6.067962518080707
72,treatment,4,0.0018527095877721167,4.276666119016055,-6.291106069394917
73,subclasses,4,0.0018527095877721167,4.290459441148391,-6.291106069394917
74,pancreatitis,4,0.0018527095877721167,4.30406509320417,-6.291106069394917
75,years,4,0.0018527095877721167,4.31748811353631,-6.291106069394917
76,de,4,0.0018527095877721167,4.330733340286331,-6.291106069394917
77,ebboetal,4,0.0018527095877721167,4.343805421853684,-6.291106069394917
78,date,4,0.0018527095877721167,4.356708826689592,-6.291106069394917
79,study,4,0.0018527095877721167,4.3694478524670215,-6.291106069394917
80,pathologic,4,0.0018527095877721167,4.382026634673881,-6.291106069394917
81,data,4,0.0018527095877721167,4.394449154672439,-6.291106069394917
82,form,4,0.0018527095877721167,4.406719247264253,-6.291106069394917
83,follow-up,4,0.0018527095877721167,4.418840607796598,-6.291106069394917
84,performed,4,0.0018527095877721167,4.430816798843313,-6.291106069394917
85,igg2,4,0.0018527095877721167,4.442651256490317,-6.291106069394917
86,society,4,0.0018527095877721167,4.454347296253507,-6.291106069394917
87,sent,4,0.0018527095877721167,4.465908118654584,-6.291106069394917
88,1144,4,0.0018527095877721167,4.477336814478207,-6.291106069394917
89,624,4,0.0018527095877721167,4.48863636973214,-6.291106069394917
90,examination,4,0.0018527095877721167,4.499809670330265,-6.291106069394917
91,cases,4,0.0018527095877721167,4.51085950651685,-6.291106069394917
92,associated,4,0.0018527095877721167,4.5217885770490405,-6.291106069394917
93,13,4,0.0018527095877721167,4.532599493153256,-6.291106069394917
94,15,4,0.0018527095877721167,4.543294782270004,-6.291106069394917
95,16,4,0.0018527095877721167,4.553876891600541,-6.291106069394917
96,17,4,0.0018527095877721167,4.564348191467836,-6.291106069394917
97,20,4,0.0018527095877721167,4.574710978503383,-6.291106069394917
98,24,4,0.0018527095877721167,4.584967478670572,-6.291106069394917
99,typical,4,0.0018527095877721167,4.59511985013459,-6.291106069394917
100,mean,4,0.0018527095877721167,4.605170185988092,-6.291106069394917
101,44,4,0.0018527095877721167,4.61512051684126,-6.291106069394917
102,32,4,0.0018527095877721167,4.624972813284271,-6.291106069394917
103,analyzed,4,0.0018527095877721167,4.634728988229636,-6.291106069394917
104,igg4plasmacells,4,0.0018527095877721167,4.6443908991413725,-6.291106069394917
105,bileduct,4,0.0018527095877721167,4.653960350157523,-6.291106069394917
106,features,3,0.0013895321908290875,4.663439094112067,-6.578788141846697
107,response,3,0.0013895321908290875,4.672828834461906,-6.578788141846697
108,characteristics,3,0.0013895321908290875,4.68213122712422,-6.578788141846697
109,suggest,3,0.0013895321908290875,4.6913478822291435,-6.578788141846697
110,previous,3,0.0013895321908290875,4.700480365792417,-6.578788141846697
111,t-cell,3,0.0013895321908290875,4.709530201312334,-6.578788141846697
112,et,3,0.0013895321908290875,4.718498871295094,-6.578788141846697
113,conditions,3,0.0013895321908290875,4.727387818712341,-6.578788141846697
114,including,3,0.0013895321908290875,4.736198448394496,-6.578788141846697
115,value,3,0.0013895321908290875,4.74493212836325,-6.578788141846697
116,lymphadenopathy,3,0.0013895321908290875,4.7535901911063645,-6.578788141846697
117,andor,3,0.0013895321908290875,4.762173934797756,-6.578788141846697
118,characteristic,3,0.0013895321908290875,4.770684624465665,-6.578788141846697
119,observed,3,0.0013895321908290875,4.77912349311153,-6.578788141846697
120,radiologic,3,0.0013895321908290875,4.787491742782046,-6.578788141846697
121,based,3,0.0013895321908290875,4.795790545596741,-6.578788141846697
122,better,3,0.0013895321908290875,4.804021044733257,-6.578788141846697
123,define,3,0.0013895321908290875,4.812184355372417,-6.578788141846697
124,n25,3,0.0013895321908290875,4.820281565605037,-6.578788141846697
125,elevation,3,0.0013895321908290875,4.8283137373023015,-6.578788141846697
126,xerostomia,3,0.0013895321908290875,4.836281906951478,-6.578788141846697
127,832,3,0.0013895321908290875,4.844187086458591,-6.578788141846697
128,treatments,3,0.0013895321908290875,4.852030263919617,-6.578788141846697
129,520,3,0.0013895321908290875,4.859812404361672,-6.578788141846697
130,nationwidestudyofigg4-relatedsystemicdisease,3,0.0013895321908290875,4.867534450455582,-6.578788141846697
131,available,3,0.0013895321908290875,4.875197323201151,-6.578788141846697
132,54m,3,0.0013895321908290875,4.882801922586371,-6.578788141846697
133,7,3,0.0013895321908290875,4.890349128221754,-6.578788141846697
134,11,3,0.0013895321908290875,4.897839799950911,-6.578788141846697
135,19,3,0.0013895321908290875,4.90527477843843,-6.578788141846697
136,21,3,0.0013895321908290875,4.912654885736052,-6.578788141846697
137,23,3,0.0013895321908290875,4.919980925828125,-6.578788141846697
138,normal,3,0.0013895321908290875,4.927253685157205,-6.578788141846697
139,52,3,0.0013895321908290875,4.9344739331306915,-6.578788141846697
140,correlation,3,0.0013895321908290875,4.941642422609304,-6.578788141846697
141,positive,3,0.0013895321908290875,4.948759890378168,-6.578788141846697
142,formation,3,0.0013895321908290875,4.955827057601261,-6.578788141846697
143,lymph,3,0.0013895321908290875,4.962844630259907,-6.578788141846697
144,node,3,0.0013895321908290875,4.969813299576001,-6.578788141846697
145,analysis,3,0.0013895321908290875,4.976733742420574,-6.578788141846697
146,1425,3,0.0013895321908290875,4.983606621708336,-6.578788141846697
147,rituximab,3,0.0013895321908290875,4.990432586778736,-6.578788141846697
148,020,3,0.0013895321908290875,4.997212273764115,-6.578788141846697
149,11100,3,0.0013895321908290875,5.003946305945459,-6.578788141846697
150,high,3,0.0013895321908290875,5.0106352940962555,-6.578788141846697
151,previously,3,0.0013895321908290875,5.017279836814924,-6.578788141846697
152,ig,3,0.0013895321908290875,5.0238805208462765,-6.578788141846697
153,cohort,2,0.0009263547938860583,5.030437921392435,-6.984253249954862
154,results,2,0.0009263547938860583,5.0369526024136295,-6.984253249954862
155,laurent,2,0.0009263547938860583,5.043425116919247,-6.984253249954862
156,pascal,2,0.0009263547938860583,5.049856007249537,-6.984253249954862
157,fc,2,0.0009263547938860583,5.056245805348308,-6.984253249954862
158,constant,2,0.0009263547938860583,5.062595033026967,-6.984253249954862
159,fragment,2,0.0009263547938860583,5.0689042022202315,-6.984253249954862
160,complement,2,0.0009263547938860583,5.075173815233827,-6.984253249954862
161,countries,2,0.0009263547938860583,5.081404364984463,-6.984253249954862
162,lesions,2,0.0009263547938860583,5.087596335232384,-6.984253249954862
163,note,2,0.0009263547938860583,5.093750200806762,-6.984253249954862
164,noted,2,0.0009263547938860583,5.099866427824199,-6.984253249954862
165,fitc,2,0.0009263547938860583,5.10594547390058,-6.984253249954862
166,nantes,2,0.0009263547938860583,5.111987788356544,-6.984253249954862
167,liferative,2,0.0009263547938860583,5.117993812416755,-6.984253249954862
168,current,2,0.0009263547938860583,5.123963979403259,-6.984253249954862
169,considered,2,0.0009263547938860583,5.1298987149230735,-6.984253249954862
170,retroperitoneal,2,0.0009263547938860583,5.135798437050262,-6.984253249954862
171,mediastinal,2,0.0009263547938860583,5.14166355650266,-6.984253249954862
172,cholangitis,2,0.0009263547938860583,5.147494476813453,-6.984253249954862
173,dacryoadenitis,2,0.0009263547938860583,5.153291594497779,-6.984253249954862
174,sialadenitis,2,0.0009263547938860583,5.159055299214529,-6.984253249954862
175,include,2,0.0009263547938860583,5.1647859739235145,-6.984253249954862
176,lymphocytes,2,0.0009263547938860583,5.170483995038151,-6.984253249954862
177,plasmocytes,2,0.0009263547938860583,5.176149732573829,-6.984253249954862
178,follicle,2,0.0009263547938860583,5.181783550292085,-6.984253249954862
179,storiform,2,0.0009263547938860583,5.187385805840755,-6.984253249954862
180,pattern,2,0.0009263547938860583,5.19295685089021,-6.984253249954862
181,entry,2,0.0009263547938860583,5.198497031265826,-6.984253249954862
182,proposed,2,0.0009263547938860583,5.204006687076795,-6.984253249954862
183,improve,2,0.0009263547938860583,5.209486152841421,-6.984253249954862
184,significantly,2,0.0009263547938860583,5.214935757608986,-6.984253249954862
185,unknown,2,0.0009263547938860583,5.220355825078324,-6.984253249954862
186,masson,2,0.0009263547938860583,5.225746673713202,-6.984253249954862
187,trichrome,2,0.0009263547938860583,5.231108616854587,-6.984253249954862
188,hematoxylin-eosin,2,0.0009263547938860583,5.236441962829949,-6.984253249954862
189,immunofluorescence,2,0.0009263547938860583,5.241747015059643,-6.984253249954862
190,national,2,0.0009263547938860583,5.247024072160486,-6.984253249954862
191,internal,2,0.0009263547938860583,5.25227342804663,-6.984253249954862
192,evaluation,2,0.0009263547938860583,5.2574953720277815,-6.984253249954862
193,nephrologists,2,0.0009263547938860583,5.262690188904886,-6.984253249954862
194,subclass,2,0.0009263547938860583,5.267858159063328,-6.984253249954862
195,physicianswere,2,0.0009263547938860583,5.272999558563747,-6.984253249954862
196,xerophthalmia,2,0.0009263547938860583,5.278114659230517,-6.984253249954862
197,physician,2,0.0009263547938860583,5.2832037287379885,-6.984253249954862
198,fever,2,0.0009263547938860583,5.288267030694535,-6.984253249954862
199,50,2,0.0009263547938860583,5.293304824724492,-6.984253249954862
200,spearman,2,0.0009263547938860583,5.298317366548036,-6.984253249954862
201,test,2,0.0009263547938860583,5.303304908059076,-6.984253249954862
202,416,2,0.0009263547938860583,5.308267697401205,-6.984253249954862
203,insufficient,2,0.0009263547938860583,5.313205979041787,-6.984253249954862
204,meningeal,2,0.0009263547938860583,5.318119993844216,-6.984253249954862
205,aipinhepaticiptln,2,0.0009263547938860583,5.3230099791384085,-6.984253249954862
206,50f,2,0.0009263547938860583,5.327876168789581,-6.984253249954862
207,72m,2,0.0009263547938860583,5.332718793265369,-6.984253249954862
208,sarcoidosis,2,0.0009263547938860583,5.337538079701318,-6.984253249954862
209,69m,2,0.0009263547938860583,5.342334251964811,-6.984253249954862
210,22,2,0.0009263547938860583,5.3471075307174685,-6.984253249954862
211,allergic,2,0.0009263547938860583,5.351858133476067,-6.984253249954862
212,76,2,0.0009263547938860583,5.356586274672012,-6.984253249954862
213,salivary,2,0.0009263547938860583,5.3612921657094255,-6.984253249954862
214,shown,2,0.0009263547938860583,5.365976015021851,-6.984253249954862
215,igg1,2,0.0009263547938860583,5.3706380281276624,-6.984253249954862
216,p,2,0.0009263547938860583,5.375278407684165,-6.984253249954862
217,antinuclear,2,0.0009263547938860583,5.37989735354046,-6.984253249954862
218,mgl,2,0.0009263547938860583,5.384495062789089,-6.984253249954862
219,0023,2,0.0009263547938860583,5.389071729816501,-6.984253249954862
220,tissue,2,0.0009263547938860583,5.393627546352362,-6.984253249954862
221,taken,2,0.0009263547938860583,5.3981627015177525,-6.984253249954862
222,92,2,0.0009263547938860583,5.402677381872279,-6.984253249954862
223,lymphoidfollicle,2,0.0009263547938860583,5.407171771460119,-6.984253249954862
224,polyclonalplasmocyte,2,0.0009263547938860583,5.4116460518550396,-6.984253249954862
225,immunohistologicstaining,2,0.0009263547938860583,5.41610040220442,-6.984253249954862
226,parotid,2,0.0009263547938860583,5.420534999272286,-6.984253249954862
227,igg3andigg4plasmacells,2,0.0009263547938860583,5.424950017481403,-6.984253249954862
228,nasalmucosa,2,0.0009263547938860583,5.429345628954441,-6.984253249954862
229,igg4plasmacells50hpf,2,0.0009263547938860583,5.43372200355424,-6.984253249954862
230,diffuse,2,0.0009263547938860583,5.438079308923196,-6.984253249954862
231,numerous,2,0.0009263547938860583,5.442417710521793,-6.984253249954862
232,igm,2,0.0009263547938860583,5.44673737166631,-6.984253249954862
233,prednisone,2,0.0009263547938860583,5.4510384535657,-6.984253249954862
234,mgkg,2,0.0009263547938860583,5.455321115357702,-6.984253249954862
235,d,2,0.0009263547938860583,5.459585514144159,-6.984253249954862
236,steroids,2,0.0009263547938860583,5.4638318050256105,-6.984253249954862
237,immunohistologic,2,0.0009263547938860583,5.4680601411351315,-6.984253249954862
238,corticosteroids,2,0.0009263547938860583,5.472270673671475,-6.984253249954862
239,azathioprine,2,0.0009263547938860583,5.476463551931511,-6.984253249954862
240,1333,2,0.0009263547938860583,5.480638923341991,-6.984253249954862
241,methotrexate,2,0.0009263547938860583,5.484796933490655,-6.984253249954862
242,imatinib,2,0.0009263547938860583,5.488937726156687,-6.984253249954862
243,indicate,2,0.0009263547938860583,5.493061443340548,-6.984253249954862
244,association,2,0.0009263547938860583,5.497168225293202,-6.984253249954862
245,tissues,2,0.0009263547938860583,5.501258210544727,-6.984253249954862
246,despite,2,0.0009263547938860583,5.5053315359323625,-6.984253249954862
247,need,2,0.0009263547938860583,5.5093883366279774,-6.984253249954862
248,pathogenesis,2,0.0009263547938860583,5.5134287461649825,-6.984253249954862
249,studies,2,0.0009263547938860583,5.517452896464707,-6.984253249954862
250,igg4-related,1,0.0004631773969430292,5.521460917862246,-7.677400430514807
251,systemic,1,0.0004631773969430292,5.5254529391317835,-7.677400430514807
252,multicenter,1,0.0004631773969430292,5.529429087511423,-7.677400430514807
253,mikael,1,0.0004631773969430292,5.53338948872752,-7.677400430514807
254,ebbo,1,0.0004631773969430292,5.537334267018537,-7.677400430514807
255,daniel,1,0.0004631773969430292,5.541263545158426,-7.677400430514807
256,michel,1,0.0004631773969430292,5.545177444479562,-7.677400430514807
257,pavic,1,0.0004631773969430292,5.54907608489522,-7.677400430514807
258,seve,1,0.0004631773969430292,5.552959584921617,-7.677400430514807
259,mohamed,1,0.0004631773969430292,5.556828061699537,-7.677400430514807
260,hamidou,1,0.0004631773969430292,5.560681631015528,-7.677400430514807
261,emmanuel,1,0.0004631773969430292,5.564520407322694,-7.677400430514807
262,andres,1,0.0004631773969430292,5.568344503761097,-7.677400430514807
263,stephane,1,0.0004631773969430292,5.572154032177765,-7.677400430514807
264,burtey,1,0.0004631773969430292,5.575949103146316,-7.677400430514807
265,chiche,1,0.0004631773969430292,5.579729825986222,-7.677400430514807
266,jacques,1,0.0004631773969430292,5.583496308781699,-7.677400430514807
267,serratrice,1,0.0004631773969430292,5.58724865840025,-7.677400430514807
268,maıte,1,0.0004631773969430292,5.5909869805108565,-7.677400430514807
269,longy-boursier,1,0.0004631773969430292,5.594711379601839,-7.677400430514807
270,marc,1,0.0004631773969430292,5.598421958998375,-7.677400430514807
271,ruivard,1,0.0004631773969430292,5.602118820879701,-7.677400430514807
272,julien,1,0.0004631773969430292,5.605802066295998,-7.677400430514807
273,haroche,1,0.0004631773969430292,5.60947179518496,-7.677400430514807
274,bertrand,1,0.0004631773969430292,5.6131281063880705,-7.677400430514807
275,godeau,1,0.0004631773969430292,5.616771097666572,-7.677400430514807
276,anne-berengere,1,0.0004631773969430292,5.62040086571715,-7.677400430514807
277,beucher,1,0.0004631773969430292,5.6240175061873385,-7.677400430514807
278,jean-marie,1,0.0004631773969430292,5.627621113690637,-7.677400430514807
279,berthelot,1,0.0004631773969430292,5.631211781821365,-7.677400430514807
280,thomas,1,0.0004631773969430292,5.634789603169249,-7.677400430514807
281,papo,1,0.0004631773969430292,5.638354669333745,-7.677400430514807
282,jean-loup,1,0.0004631773969430292,5.641907070938114,-7.677400430514807
283,pennaforte,1,0.0004631773969430292,5.645446897643238,-7.677400430514807
284,audrey,1,0.0004631773969430292,5.648974238161206,-7.677400430514807
285,benyamine,1,0.0004631773969430292,5.652489180268651,-7.677400430514807
286,noemie,1,0.0004631773969430292,5.655991810819852,-7.677400430514807
287,jourde,1,0.0004631773969430292,5.659482215759621,-7.677400430514807
288,cedric,1,0.0004631773969430292,5.662960480135946,-7.677400430514807
289,landron,1,0.0004631773969430292,5.666426688112432,-7.677400430514807
290,roblot,1,0.0004631773969430292,5.66988092298052,-7.677400430514807
291,olivier,1,0.0004631773969430292,5.673323267171493,-7.677400430514807
292,moranne,1,0.0004631773969430292,5.676753802268282,-7.677400430514807
293,christine,1,0.0004631773969430292,5.680172609017068,-7.677400430514807
294,silvain,1,0.0004631773969430292,5.683579767338681,-7.677400430514807
295,brigitte,1,0.0004631773969430292,5.68697535633982,-7.677400430514807
296,granel,1,0.0004631773969430292,5.69035945432406,-7.677400430514807
297,fanny,1,0.0004631773969430292,5.6937321388027,-7.677400430514807
298,bernard,1,0.0004631773969430292,5.697093486505405,-7.677400430514807
299,veronique,1,0.0004631773969430292,5.700443573390687,-7.677400430514807
300,veit,1,0.0004631773969430292,5.703782474656201,-7.677400430514807
301,karin,1,0.0004631773969430292,5.707110264748875,-7.677400430514807
302,mazodier,1,0.0004631773969430292,5.71042701737487,-7.677400430514807
303,emmanuelle,1,0.0004631773969430292,5.713732805509369,-7.677400430514807
304,bernit,1,0.0004631773969430292,5.717027701406222,-7.677400430514807
305,hugues,1,0.0004631773969430292,5.720311776607412,-7.677400430514807
306,rousset,1,0.0004631773969430292,5.723585101952381,-7.677400430514807
307,jose,1,0.0004631773969430292,5.726847747587197,-7.677400430514807
308,boucraut,1,0.0004631773969430292,5.730099782973574,-7.677400430514807
309,jean-jacques,1,0.0004631773969430292,5.733341276897746,-7.677400430514807
310,boffa,1,0.0004631773969430292,5.736572297479192,-7.677400430514807
311,pierre-jean,1,0.0004631773969430292,5.739792912179234,-7.677400430514807
312,weiller,1,0.0004631773969430292,5.7430031878094825,-7.677400430514807
313,gilles,1,0.0004631773969430292,5.746203190540153,-7.677400430514807
314,kaplanski,1,0.0004631773969430292,5.749392985908253,-7.677400430514807
315,pierre,1,0.0004631773969430292,5.752572638825633,-7.677400430514807
316,aucouturier,1,0.0004631773969430292,5.755742213586912,-7.677400430514807
317,jean-robert,1,0.0004631773969430292,5.75890177387728,-7.677400430514807
318,harle,1,0.0004631773969430292,5.762051382780177,-7.677400430514807
319,nicolas,1,0.0004631773969430292,5.765191102784844,-7.677400430514807
320,schleinitz,1,0.0004631773969430292,5.768320995793772,-7.677400430514807
321,introduction,1,0.0004631773969430292,5.771441123130016,-7.677400430514807
322,abstract,1,0.0004631773969430292,5.7745515455444085,-7.677400430514807
323,igg4-relatedsystemicdiseaseisnowrecognizedasasystemicdiseasethatmayaffectvariousorgansthediagnosisisusually,1,0.0004631773969430292,5.777652323222656,-7.677400430514807
324,madeinpatientswhopresentwithelevatedigg4inserumandtissue,1,0.0004631773969430292,5.780743515792329,-7.677400430514807
325,isundernormalconditionsoneofthelessabundantigg,1,0.0004631773969430292,5.783825182329737,-7.677400430514807
326,infiltrationofdiseasedorgansbynumerousigg4plasmacellsinthe,1,0.0004631773969430292,5.786897381366708,-7.677400430514807
327,poorly,1,0.0004631773969430292,5.7899601708972535,-7.677400430514807
328,binds,1,0.0004631773969430292,5.793013608384144,-7.677400430514807
329,absenceofvalidateddiagnosiscriteriawereporttheclinicallaboratory,1,0.0004631773969430292,5.796057750765372,-7.677400430514807
330,receptorsand,1,0.0004631773969430292,5.799092654460526,-7.677400430514807
331,notactivate,1,0.0004631773969430292,5.802118375377063,-7.677400430514807
332,clasand,1,0.0004631773969430292,5.805134968916488,-7.677400430514807
333,nationwide,1,0.0004631773969430292,5.808142489980444,-7.677400430514807
334,sical,1,0.0004631773969430292,5.811140992976701,-7.677400430514807
335,pathway,1,0.0004631773969430292,5.814130531825066,-7.677400430514807
336,itsroleinhumoralimmuneresponsesisunclear,1,0.0004631773969430292,5.817111159963204,-7.677400430514807
337,cohortwealsoreportthetreatmentoutcomeandshowthatdespitethe,1,0.0004631773969430292,5.820082930352362,-7.677400430514807
338,relative,1,0.0004631773969430292,5.823045895483019,-7.677400430514807
339,expression,1,0.0004631773969430292,5.82600010738045,-7.677400430514807
340,efficacyofcorticosteroidsasecond-linetreatmentisfrequentlynecessary,1,0.0004631773969430292,5.8289456176102075,-7.677400430514807
341,isotypeamongantibodiesincreaseswithiterativeantigenicchaltheclinicalfindingsinourpatientsarenotdifferentfromtheresultsof,1,0.0004631773969430292,5.831882477283517,-7.677400430514807
342,lenges1andthatigg4displaysantiinflammatoryproperties19a,1,0.0004631773969430292,5.834810737062605,-7.677400430514807
343,eastern,1,0.0004631773969430292,5.8377304471659395,-7.677400430514807
344,moderate,1,0.0004631773969430292,5.840641657373398,-7.677400430514807
345,increase,1,0.0004631773969430292,5.84354441703136,-7.677400430514807
346,refindingshoweversuggestatleastinsomepatientsamorebroadpoly-,1,0.0004631773969430292,5.846438775057725,-7.677400430514807
347,portedinallergicdiseaseparasiticinfectionandseveralinflamclonalbcellactivationthantheskewedigg4switchpreviouslyreported,1,0.0004631773969430292,5.849324779946859,-7.677400430514807
348,matory,1,0.0004631773969430292,5.8522024797744745,-7.677400430514807
349,lymphoproliferative,1,0.0004631773969430292,5.855071922202427,-7.677400430514807
350,conditions2,1,0.0004631773969430292,5.857933154483459,-7.677400430514807
351,knowledge,1,0.0004631773969430292,5.860786223465865,-7.677400430514807
352,observations,1,0.0004631773969430292,5.863631175598097,-7.677400430514807
353,strongly,1,0.0004631773969430292,5.8664680569332965,-7.677400430514807
354,implication,1,0.0004631773969430292,5.869296913133774,-7.677400430514807
355,depen-,1,0.0004631773969430292,5.872117789475416,-7.677400430514807
356,relation,1,0.0004631773969430292,5.87493073085203,-7.677400430514807
357,dentb-cellpolyclonalactivationinigg4-relatedsystemicdiseaseprob-,1,0.0004631773969430292,5.877735781779639,-7.677400430514807
358,hamano,1,0.0004631773969430292,5.8805329864007,-7.677400430514807
359,al8,1,0.0004631773969430292,5.883322388488279,-7.677400430514807
360,ablyatleastinpartunderthecontrolofthelperfollicularcells,1,0.0004631773969430292,5.886104031450156,-7.677400430514807
361,autoimmune,1,0.0004631773969430292,5.8888779583328805,-7.677400430514807
362,hypergammaglobulinemia,1,0.0004631773969430292,5.8916442118257715,-7.677400430514807
363,medicine20129149y56,1,0.0004631773969430292,5.8944028342648505,-7.677400430514807
364,sarles,1,0.0004631773969430292,5.8971538676367405,-7.677400430514807
365,al16,1,0.0004631773969430292,5.8998973535824915,-7.677400430514807
366,assess,1,0.0004631773969430292,5.902633333401366,-7.677400430514807
367,repartition,1,0.0004631773969430292,5.905361848054571,-7.677400430514807
368,descriptions,1,0.0004631773969430292,5.908082938168931,-7.677400430514807
369,types,1,0.0004631773969430292,5.910796644040527,-7.677400430514807
370,abbreviations,1,0.0004631773969430292,5.91350300563827,-7.677400430514807
371,fluorescein,1,0.0004631773969430292,5.916202062607435,-7.677400430514807
372,inflammatoryorganinvolvementhavebeenrecognizedasmaniisothiocyanateigg4-rsdigg4-relatedsystemicdiseasemab,1,0.0004631773969430292,5.918893854273146,-7.677400430514807
373,festationsofigg4-relatedsystemicdiseaseigg4-rsd9howmonoclonalantibodysdstandarddeviationth2thelper2,1,0.0004631773969430292,5.921578419643816,-7.677400430514807
374,series,1,0.0004631773969430292,5.924255797414532,-7.677400430514807
375,western,1,0.0004631773969430292,5.926926025970411,-7.677400430514807
376,fromuniversite,1,0.0004631773969430292,5.929589143389895,-7.677400430514807
377,delamediterraneeaix-marseilleiimeldsblcjs,1,0.0004631773969430292,5.932245187448011,-7.677400430514807
378,referencedescytopeniesauto-immunesbgodeauhoˆpitalhenrimondor,1,0.0004631773969430292,5.934894195619588,-7.677400430514807
379,abnjbgraneljbpjwgkjrhnsmarseilleservicedemedecine,1,0.0004631773969430292,5.937536205082426,-7.677400430514807
380,assistancepublique-hoˆpitauxdeparisuniversiteparis12creteilservicede,1,0.0004631773969430292,5.940171252720432,-7.677400430514807
381,internemelcvvkmebgkjrhnsservicedenephrologiesb,1,0.0004631773969430292,5.942799375126701,-7.677400430514807
382,medecineinterneabbcentrehospitalieruniversitairedangersangers,1,0.0004631773969430292,5.945420608606575,-7.677400430514807
383,njandlaboratoiredimmunologiejbhoˆpitaldelaconceptionassis-,1,0.0004631773969430292,5.948034989180646,-7.677400430514807
384,servicedemedecineinternetphoˆpitalbichat-claudebernardassistance,1,0.0004631773969430292,5.950642552587727,-7.677400430514807
385,tancepublique-hoˆpitauxdemarseillemarseilleservicedanatomiepatho-,1,0.0004631773969430292,5.953243334287785,-7.677400430514807
386,publique-hoˆpitauxdeparisuniversite,1,0.0004631773969430292,5.955837369464831,-7.677400430514807
387,paris7parisservicedemedecine,1,0.0004631773969430292,5.958424693029782,-7.677400430514807
388,logiqueetdeneuropathologieldandservicedemedecineinternejs,1,0.0004631773969430292,5.961005339623274,-7.677400430514807
389,internejlphoˆpitalrobertdebrecentrehospitalieruniversitairedereims,1,0.0004631773969430292,5.963579343618446,-7.677400430514807
390,abpjwhoˆpitaldelatimoneassistancepublique-hoˆpitauxdemarseille,1,0.0004631773969430292,5.966146739123692,-7.677400430514807
391,reimsservicedemedecineinterneclprandservicedegastroentermarseilleservicedemedecineinterne-oncologiemphoˆpitaldinstruction,1,0.0004631773969430292,5.968707559985366,-7.677400430514807
392,ologiecscentrehospitalieruniversitairelamiletriepoitiersservicede,1,0.0004631773969430292,5.971261839790462,-7.677400430514807
393,desarmeesdesgenetteslyonservicedemedecineinternepshoˆtel-dieu,1,0.0004631773969430292,5.973809611869261,-7.677400430514807
394,nephrologieomcentrehospitalieruniversitairedeniceniceservicede,1,0.0004631773969430292,5.976350909297934,-7.677400430514807
395,hospicescivilsdelyonuniversiteclaudebernardlyon1lyonservicede,1,0.0004631773969430292,5.978885764901122,-7.677400430514807
396,medecineinternebgranelfbhoˆpitalnordassistancepublique-hoˆpitaux,1,0.0004631773969430292,5.981414211254481,-7.677400430514807
397,medecineinternemh,1,0.0004631773969430292,5.983936280687191,-7.677400430514807
398,servicederhumatologie,1,0.0004631773969430292,5.986452005284438,-7.677400430514807
399,jmbhoˆtel,1,0.0004631773969430292,5.988961416889864,-7.677400430514807
400,dieu,1,0.0004631773969430292,5.991464547107982,-7.677400430514807
401,demarseillemarseilleservicedemedecineinternehrcentrehospitalier,1,0.0004631773969430292,5.993961427306569,-7.677400430514807
402,centre,1,0.0004631773969430292,5.996452088619021,-7.677400430514807
403,hospitalier,1,0.0004631773969430292,5.998936561946683,-7.677400430514807
404,universitaire,1,0.0004631773969430292,6.0014148779611505,-7.677400430514807
405,service,1,0.0004631773969430292,6.003887067106539,-7.677400430514807
406,medecine,1,0.0004631773969430292,6.0063531596017325,-7.677400430514807
407,lyon-sudhospicescivilsdelyonpierrebenitelaboratoireneurobiologie,1,0.0004631773969430292,6.008813185442595,-7.677400430514807
408,interneeacliniquemedicalebcentrehospitalieruniversitairedestras-,1,0.0004631773969430292,6.0112671744041615,-7.677400430514807
409,des,1,0.0004631773969430292,6.013715156042802,-7.677400430514807
410,interactions,1,0.0004631773969430292,6.016157159698354,-7.677400430514807
411,cellulaires,1,0.0004631773969430292,6.018593214496234,-7.677400430514807
412,neurophysiopathologie,1,0.0004631773969430292,6.021023349349527,-7.677400430514807
413,nicn,1,0.0004631773969430292,6.023447592961033,-7.677400430514807
414,jb,1,0.0004631773969430292,6.025865973825314,-7.677400430514807
415,cnrs,1,0.0004631773969430292,6.028278520230698,-7.677400430514807
416,bourgstrasbourginserm,1,0.0004631773969430292,6.030685260261263,-7.677400430514807
417,u897servicedemedecineinterneettropicale,1,0.0004631773969430292,6.0330862217988015,-7.677400430514807
418,umr6184facultedemedecineuniversiteaix-marseillemarseilleservice,1,0.0004631773969430292,6.035481432524756,-7.677400430514807
419,mlbhoˆpitalsaint-andrecentrehospitalieruniversitairedebordeaux,1,0.0004631773969430292,6.037870919922137,-7.677400430514807
420,denephrologiejjbhoˆpitaltenonassistancepublique-hoˆpitauxdeparis,1,0.0004631773969430292,6.040254711277414,-7.677400430514807
421,universitebordeaux2victor-segalenbordeauxservicedemedecineinterne,1,0.0004631773969430292,6.042632833682381,-7.677400430514807
422,universitepierreetmariecurieparisinsermumr-s938hoˆpitalsaint-,1,0.0004631773969430292,6.045005314036012,-7.677400430514807
423,mrhoˆteldieucentrehospitalieruniversitairedeclermont-ferrandser-,1,0.0004631773969430292,6.0473721790462776,-7.677400430514807
424,antoinepauniversitepierreetmariecurieparisandcentredimmunovicedemedecineinterneetcentredereferencedesmaladiesauto-immuneset,1,0.0004631773969430292,6.049733455231958,-7.677400430514807
425,logie,1,0.0004631773969430292,6.052089168924417,-7.677400430514807
426,marseille-luminy,1,0.0004631773969430292,6.054439346269371,-7.677400430514807
427,ns,1,0.0004631773969430292,6.056784013228625,-7.677400430514807
428,universite,1,0.0004631773969430292,6.059123195581797,-7.677400430514807
429,la,1,0.0004631773969430292,6.061456918928017,-7.677400430514807
430,mediterranee,1,0.0004631773969430292,6.063785208687608,-7.677400430514807
431,case,1,0.0004631773969430292,6.066108090103747,-7.677400430514807
432,906,1,0.0004631773969430292,6.068425588244111,-7.677400430514807
433,systemiquesraresjhhoˆpitalpitie-salpeˆtriereassistancepublique-hoˆpitaux,1,0.0004631773969430292,6.07073772800249,-7.677400430514807
434,campusdeluminymarseillefrance,1,0.0004631773969430292,6.073044534100405,-7.677400430514807
435,deparisuniversiteparis6parisservicedemedecineinterneetcentrede,1,0.0004631773969430292,6.075346031088684,-7.677400430514807
436,theauthorshavenofundingorconflictsofinteresttodisclose,1,0.0004631773969430292,6.077642243349034,-7.677400430514807
437,copyright2012bylippincottwilliamswilkins,1,0.0004631773969430292,6.07993319509559,-7.677400430514807
438,reprintsnicolasschleinitzmdservicedemedecineinternechu,1,0.0004631773969430292,6.082218910376446,-7.677400430514807
439,issn0025-7974,1,0.0004631773969430292,6.0844994130751715,-7.677400430514807
440,conceptionap-hm13385marseillecedex05france,1,0.0004631773969430292,6.0867747269123065,-7.677400430514807
441,doi101097md0b013e3182433d77,1,0.0004631773969430292,6.089044875446846,-7.677400430514807
442,e-mailnicolasschleinitzap-hmfr,1,0.0004631773969430292,6.091309882077698,-7.677400430514807
443,49,1,0.0004631773969430292,6.093569770045136,-7.677400430514807
444,multiorgan,1,0.0004631773969430292,6.095824562432225,-7.677400430514807
445,lymphopro-,1,0.0004631773969430292,6.09807428216624,-7.677400430514807
446,inclusioncriteria,1,0.0004631773969430292,6.100318952020064,-7.677400430514807
447,syndrome,1,0.0004631773969430292,6.102558594613569,-7.677400430514807
448,molps11,1,0.0004631773969430292,6.104793232414985,-7.677400430514807
449,pre-,1,0.0004631773969430292,6.1070228877422545,-7.677400430514807
450,international,1,0.0004631773969430292,6.1092475827643655,-7.677400430514807
451,consensus,1,0.0004631773969430292,6.111467339502679,-7.677400430514807
452,senting,1,0.0004631773969430292,6.113682179832232,-7.677400430514807
453,diagnostic,1,0.0004631773969430292,6.115892125483034,-7.677400430514807
454,cho-,1,0.0004631773969430292,6.118097198041348,-7.677400430514807
455,langitis,1,0.0004631773969430292,6.12029741895095,-7.677400430514807
456,kuttner,1,0.0004631773969430292,6.1224928095143865,-7.677400430514807
457,inflammatoryinvolvement,1,0.0004631773969430292,6.124683390894205,-7.677400430514807
458,1or,1,0.0004631773969430292,6.126869184114185,-7.677400430514807
459,scletumorandinflammatorypseudotumorstodatetherearenoin-,1,0.0004631773969430292,6.129050210060545,-7.677400430514807
460,rosing,1,0.0004631773969430292,6.131226489483141,-7.677400430514807
461,pseuternationallyrecognizeddiagnosticcriteriaforigg4-rsdcrite-,1,0.0004631773969430292,6.133398042996649,-7.677400430514807
462,dotumors,1,0.0004631773969430292,6.135564891081739,-7.677400430514807
463,interstitial,1,0.0004631773969430292,6.137727054086234,-7.677400430514807
464,riahavebeenproposedforautoimmunepancreatitisandacutoff,1,0.0004631773969430292,6.139884552226255,-7.677400430514807
465,nephritis,1,0.0004631773969430292,6.142037405587356,-7.677400430514807
466,hypophysitis,1,0.0004631773969430292,6.144185634125646,-7.677400430514807
467,135,1,0.0004631773969430292,6.1463292576688975,-7.677400430514807
468,single,1,0.0004631773969430292,6.148468295917647,-7.677400430514807
469,radial,1,0.0004631773969430292,6.150602768446279,-7.677400430514807
470,immunodiffu-,1,0.0004631773969430292,6.152732694704104,-7.677400430514807
471,mikuliczdiseaseandkuttnertumorinflammatoryaorticansionornephelometryresultedinahighrateofspecificity97,1,0.0004631773969430292,6.154858094016418,-7.677400430514807
472,eurysm,1,0.0004631773969430292,6.156978985585555,-7.677400430514807
473,sensitivity,1,0.0004631773969430292,6.159095388491933,-7.677400430514807
474,95,1,0.0004631773969430292,6.161207321695077,-7.677400430514807
475,allowing,1,0.0004631773969430292,6.163314804034641,-7.677400430514807
476,differentiation,1,0.0004631773969430292,6.16541785423142,-7.677400430514807
477,autoim-,1,0.0004631773969430292,6.1675164908883415,-7.677400430514807
478,measured,1,0.0004631773969430292,6.169610732491456,-7.677400430514807
479,nephemune,1,0.0004631773969430292,6.171700597410915,-7.677400430514807
480,pancreatic,1,0.0004631773969430292,6.173786103901937,-7.677400430514807
481,diseases6y81214,1,0.0004631773969430292,6.175867270105761,-7.677400430514807
482,lometry,1,0.0004631773969430292,6.1779441140506,-7.677400430514807
483,elisa,1,0.0004631773969430292,6.180016653652572,-7.677400430514807
484,histopathologic,1,0.0004631773969430292,6.182084906716632,-7.677400430514807
485,cutoff,1,0.0004631773969430292,6.184148890937483,-7.677400430514807
486,extended,1,0.0004631773969430292,6.186208623900494,-7.677400430514807
487,thediagnosisofigg4-rsd,1,0.0004631773969430292,6.18826412308259,-7.677400430514807
488,infilcharacteristic,1,0.0004631773969430292,6.1903154058531475,-7.677400430514807
489,tration,1,0.0004631773969430292,6.192362489474872,-7.677400430514807
490,immunohistology,1,0.0004631773969430292,6.194405391104672,-7.677400430514807
491,infiltrate,1,0.0004631773969430292,6.19644412779452,-7.677400430514807
492,dominated,1,0.0004631773969430292,6.198478716492308,-7.677400430514807
493,some-,1,0.0004631773969430292,6.20050917404269,-7.677400430514807
494,performedand4exclusionofotherdiseases,1,0.0004631773969430292,6.202535517187923,-7.677400430514807
495,times,1,0.0004631773969430292,6.20455776256869,-7.677400430514807
496,lymphoid,1,0.0004631773969430292,6.206575926724928,-7.677400430514807
497,formations,1,0.0004631773969430292,6.208590026096629,-7.677400430514807
498,obliterative,1,0.0004631773969430292,6.210600077024653,-7.677400430514807
499,evaluationoftreatmentresponse,1,0.0004631773969430292,6.212606095751519,-7.677400430514807
500,phlebitis,1,0.0004631773969430292,6.214608098422191,-7.677400430514807
501,marked,1,0.0004631773969430292,6.2166061010848646,-7.677400430514807
502,igg4iggplasmacellratio904onimmunohistologyusually,1,0.0004631773969430292,6.218600119691729,-7.677400430514807
503,physicians,1,0.0004631773969430292,6.220590170099739,-7.677400430514807
504,asked,1,0.0004631773969430292,6.222576268071369,-7.677400430514807
505,answer,1,0.0004631773969430292,6.22455842927536,-7.677400430514807
506,following,1,0.0004631773969430292,6.226536669287466,-7.677400430514807
507,ascertain,1,0.0004631773969430292,6.2285110035911835,-7.677400430514807
508,questionsregardingthediseaseevolutiondidtheclinicalstatus,1,0.0004631773969430292,6.230481447578482,-7.677400430514807
509,thediagnosis5,1,0.0004631773969430292,6.2324480165505225,-7.677400430514807
510,level,1,0.0004631773969430292,6.234410725718371,-7.677400430514807
511,decrease,1,0.0004631773969430292,6.236369590203704,-7.677400430514807
512,boththemechanismsofigg4plasmacellinfiltrationand,1,0.0004631773969430292,6.238324625039508,-7.677400430514807
513,abnormalities,1,0.0004631773969430292,6.240275845170769,-7.677400430514807
514,production,1,0.0004631773969430292,6.2422232654551655,-7.677400430514807
515,role,1,0.0004631773969430292,6.244166900663736,-7.677400430514807
516,remain,1,0.0004631773969430292,6.246106765481563,-7.677400430514807
517,effective,1,0.0004631773969430292,6.248042874508429,-7.677400430514807
518,improved,1,0.0004631773969430292,6.249975242259483,-7.677400430514807
519,physiciansevaluation,1,0.0004631773969430292,6.251903883165888,-7.677400430514807
520,igg4-rsdwecreatedamulticenterregistryinfrancewereport,1,0.0004631773969430292,6.253828811575473,-7.677400430514807
521,characterhistologicanalysis,1,0.0004631773969430292,6.255750041753367,-7.677400430514807
522,isticsof25patients,1,0.0004631773969430292,6.257667587882639,-7.677400430514807
523,tissuebiopsieswereallanalyzedbyconventionalmicroscopy,1,0.0004631773969430292,6.259581464064923,-7.677400430514807
524,patientsandmethods,1,0.0004631773969430292,6.261491684321042,-7.677400430514807
525,anti,1,0.0004631773969430292,6.263398262591624,-7.677400430514807
526,igg1-fluorescein,1,0.0004631773969430292,6.26530121273771,-7.677400430514807
527,isothiocyanate,1,0.0004631773969430292,6.267200548541362,-7.677400430514807
528,monoclonal,1,0.0004631773969430292,6.269096283706261,-7.677400430514807
529,antibody,1,0.0004631773969430292,6.270988431858299,-7.677400430514807
530,ascertainmentofpatients,1,0.0004631773969430292,6.272877006546167,-7.677400430514807
531,maballfromthebindingsitebirminghamukwereanpatientswereascertainedinseveralwaysinfebruary2009,1,0.0004631773969430292,6.274762021241939,-7.677400430514807
532,alyzed,1,0.0004631773969430292,6.2766434893416445,-7.677400430514807
533,members,1,0.0004631773969430292,6.278521424165844,-7.677400430514807
534,assessed,1,0.0004631773969430292,6.280395838960195,-7.677400430514807
535,semi-quantitative,1,0.0004631773969430292,6.282266746896006,-7.677400430514807
536,pamedicine,1,0.0004631773969430292,6.284134161070802,-7.677400430514807
537,e-mail,1,0.0004631773969430292,6.285998094508865,-7.677400430514807
538,describing,1,0.0004631773969430292,6.2878585601617845,-7.677400430514807
539,thologyexamination,1,0.0004631773969430292,6.289715570908998,-7.677400430514807
540,no-,1,0.0004631773969430292,6.29156913955832,-7.677400430514807
541,present,1,0.0004631773969430292,6.293419278846481,-7.677400430514807
542,abundantorinigg4-rsd,1,0.0004631773969430292,6.295266001439646,-7.677400430514807
543,inquiring,1,0.0004631773969430292,6.297109319933935,-7.677400430514807
544,orhad,1,0.0004631773969430292,6.298949246855942,-7.677400430514807
545,previouslybeen,1,0.0004631773969430292,6.300785794663244,-7.677400430514807
546,tenseigg4,1,0.0004631773969430292,6.302618975744905,-7.677400430514807
547,plasmacellinfiltratewhenthenumberof,1,0.0004631773969430292,6.304448802421981,-7.677400430514807
548,followingpatientswithigg4-rsdandiftheywouldagreeto,1,0.0004631773969430292,6.306275286948016,-7.677400430514807
549,enter,1,0.0004631773969430292,6.3080984415095305,-7.677400430514807
550,description,1,0.0004631773969430292,6.309918278226516,-7.677400430514807
551,june,1,0.0004631773969430292,6.311734809152915,-7.677400430514807
552,2009,1,0.0004631773969430292,6.313548046277095,-7.677400430514807
553,table1,1,0.0004631773969430292,6.315358001522335,-7.677400430514807
554,clinicalfeaturesofpatientswithigg4-rsd,1,0.0004631773969430292,6.317164686747284,-7.677400430514807
555,congress,1,0.0004631773969430292,6.318968113746434,-7.677400430514807
556,invited,1,0.0004631773969430292,6.320768294250582,-7.677400430514807
557,atpresentation,1,0.0004631773969430292,6.322565239927284,-7.677400430514807
558,announcement,1,0.0004631773969430292,6.324358962381311,-7.677400430514807
559,website,1,0.0004631773969430292,6.326149473155099,-7.677400430514807
560,nephrology,1,0.0004631773969430292,6.327936783729195,-7.677400430514807
561,investigators,1,0.0004631773969430292,6.329720905522696,-7.677400430514807
562,performing,1,0.0004631773969430292,6.331501849893691,-7.677400430514807
563,meafeature,1,0.0004631773969430292,6.333279628139691,-7.677400430514807
564,surementswereaskedtoprovidethenamesofphysicianswho,1,0.0004631773969430292,6.335054251498059,-7.677400430514807
565,samples,1,0.0004631773969430292,6.336825731146441,-7.677400430514807
566,symptom,1,0.0004631773969430292,6.338594078203183,-7.677400430514807
567,context,1,0.0004631773969430292,6.340359303727752,-7.677400430514807
568,suspicion,1,0.0004631773969430292,6.342121418721152,-7.677400430514807
569,asthenia,1,0.0004631773969430292,6.343880434126331,-7.677400430514807
570,1456,1,0.0004631773969430292,6.345636360828596,-7.677400430514807
571,3-page,1,0.0004631773969430292,6.3473892096560105,-7.677400430514807
572,request-,1,0.0004631773969430292,6.349138991379798,-7.677400430514807
573,weightloss,1,0.0004631773969430292,6.35088571671474,-7.677400430514807
574,ingdetailedinformationonthedemographicandclinicalcharacabdominalpain,1,0.0004631773969430292,6.352629396319567,-7.677400430514807
575,1040,1,0.0004631773969430292,6.354370040797351,-7.677400430514807
576,teristics,1,0.0004631773969430292,6.3561076606958915,-7.677400430514807
577,ofthe,1,0.0004631773969430292,6.3578422665081,-7.677400430514807
578,corresponding,1,0.0004631773969430292,6.359573868672378,-7.677400430514807
579,responses,1,0.0004631773969430292,6.361302477572996,-7.677400430514807
580,andthepatientslateststatusthefirstpatientwasregisteredin,1,0.0004631773969430292,6.363028103540465,-7.677400430514807
581,coughordyspnea,1,0.0004631773969430292,6.364750756851911,-7.677400430514807
582,february2009andbetweenthenandoctober201025patients,1,0.0004631773969430292,6.366470447731438,-7.677400430514807
583,wereenteredintotheregistryinmay2010a2-pagefollow-up,1,0.0004631773969430292,6.368187186350492,-7.677400430514807
584,diarrhea,1,0.0004631773969430292,6.369900982828227,-7.677400430514807
585,entered,1,0.0004631773969430292,6.371611847231857,-7.677400430514807
586,pruritus,1,0.0004631773969430292,6.373319789577012,-7.677400430514807
587,theregistryuptothatdaterequestinginformationonthestatus,1,0.0004631773969430292,6.375024819828097,-7.677400430514807
588,visualdisorder,1,0.0004631773969430292,6.376726947898627,-7.677400430514807
589,constructionofregistry,1,0.0004631773969430292,6.3784261836515865,-7.677400430514807
590,jaundice,1,0.0004631773969430292,6.380122536899765,-7.677400430514807
591,maintain,1,0.0004631773969430292,6.3818160174060985,-7.677400430514807
592,anonymity,1,0.0004631773969430292,6.3835066348840055,-7.677400430514807
593,identifying,1,0.0004631773969430292,6.385194398997726,-7.677400430514807
594,salivaryglandswelling,1,0.0004631773969430292,6.386879319362645,-7.677400430514807
595,collectedwerethepatientsinitialsbirthdateandsexthenames,1,0.0004631773969430292,6.38856140554563,-7.677400430514807
596,hepatomegaly,1,0.0004631773969430292,6.39024066706535,-7.677400430514807
597,addressesphonenumberssocialsecuritynumbersandorhosabnormalpulmonaryauscultation,1,0.0004631773969430292,6.391917113392602,-7.677400430514807
598,pitalnumberswerenotprovidedduplicateentriesfromdifferent,1,0.0004631773969430292,6.393590753950631,-7.677400430514807
599,splenomegaly,1,0.0004631773969430292,6.395261598115449,-7.677400430514807
600,avoided,1,0.0004631773969430292,6.396929655216146,-7.677400430514807
601,cross-checking,1,0.0004631773969430292,6.398594934535208,-7.677400430514807
602,initials,1,0.0004631773969430292,6.400257445308821,-7.677400430514807
603,lacrimalglandswelling,1,0.0004631773969430292,6.401917196727186,-7.677400430514807
604,andbirthdates,1,0.0004631773969430292,6.403574197934815,-7.677400430514807
605,high-power,1,0.0004631773969430292,6.405228458030842,-7.677400430514807
606,field,1,0.0004631773969430292,6.406879986069314,-7.677400430514807
607,igg4igg,1,0.0004631773969430292,6.408528791059498,-7.677400430514807
608,table2,1,0.0004631773969430292,6.410174881966167,-7.677400430514807
609,organinvolvementofpatientswithigg4-rsd,1,0.0004631773969430292,6.411818267709897,-7.677400430514807
610,plasmacellratiowereavailabletheywerenoted,1,0.0004631773969430292,6.413458957167357,-7.677400430514807
611,statisticalanalysis,1,0.0004631773969430292,6.415096959171596,-7.677400430514807
612,organinvolvement,1,0.0004631773969430292,6.416732282512326,-7.677400430514807
613,expressed,1,0.0004631773969430292,6.418364935936212,-7.677400430514807
614,geometrical,1,0.0004631773969430292,6.419994928147142,-7.677400430514807
615,means,1,0.0004631773969430292,6.421622267806518,-7.677400430514807
616,adenopathy,1,0.0004631773969430292,6.423246963533519,-7.677400430514807
617,1976,1,0.0004631773969430292,6.424869023905388,-7.677400430514807
618,standarddeviationssdcorrelationsofigg4withigg1igg2,1,0.0004631773969430292,6.42648845745769,-7.677400430514807
619,sclerosingpancreatitis,1,0.0004631773969430292,6.428105272684596,-7.677400430514807
620,1352,1,0.0004631773969430292,6.429719478039138,-7.677400430514807
621,rank,1,0.0004631773969430292,6.431331081933479,-7.677400430514807
622,usinggraphpadprismv40,1,0.0004631773969430292,6.432940092739179,-7.677400430514807
623,interstitialnephritis,1,0.0004631773969430292,6.434546518787453,-7.677400430514807
624,sclerosingcholangitis,1,0.0004631773969430292,6.436150368369428,-7.677400430514807
625,retroperitonealfibrosis,1,0.0004631773969430292,6.437751649736401,-7.677400430514807
626,aorticinvolvement,1,0.0004631773969430292,6.439350371100098,-7.677400430514807
627,patientcharacteristics,1,0.0004631773969430292,6.440946540632921,-7.677400430514807
628,abdominalaorta,1,0.0004631773969430292,6.4425401664681985,-7.677400430514807
629,fulfilled,1,0.0004631773969430292,6.444131256700441,-7.677400430514807
630,incluthoracicaorta,1,0.0004631773969430292,6.4457198193855785,-7.677400430514807
631,sioncriteriaandwereretainedforthestudymostwererecruited,1,0.0004631773969430292,6.447305862541213,-7.677400430514807
632,interstitialpneumonitis,1,0.0004631773969430292,6.448889394146858,-7.677400430514807
633,gastroenterologists,1,0.0004631773969430292,6.450470422144176,-7.677400430514807
634,rheumahypophysitis,1,0.0004631773969430292,6.452048954437226,-7.677400430514807
635,tologists,1,0.0004631773969430292,6.453624998892692,-7.677400430514807
636,excluded,1,0.0004631773969430292,6.455198563340122,-7.677400430514807
637,inflammatorypseudotumor,1,0.0004631773969430292,6.456769655572163,-7.677400430514807
638,patientshadtypicalorganinvolvementbutigg4levelsg135gl,1,0.0004631773969430292,6.45833828334479,-7.677400430514807
639,5patientshadtypicalorganinvolvementandhighserumigg4,1,0.0004631773969430292,6.459904454377535,-7.677400430514807
640,orbital,1,0.0004631773969430292,6.461468176353717,-7.677400430514807
641,hepatic,1,0.0004631773969430292,6.46302945692067,-7.677400430514807
642,anotherdiagnosisgougerot-sjogrenin2patientsandrelapsing,1,0.0004631773969430292,6.464588303689961,-7.677400430514807
643,table3,1,0.0004631773969430292,6.466144724237619,-7.677400430514807
644,characteristicsof25patientswithigg4-rsd,1,0.0004631773969430292,6.467698726104354,-7.677400430514807
645,agesexyr,1,0.0004631773969430292,6.4692503167957724,-7.677400430514807
646,igg4-rsdmanifestation,1,0.0004631773969430292,6.470799503782602,-7.677400430514807
647,allergy,1,0.0004631773969430292,6.472346294500901,-7.677400430514807
648,inflammatorycondition,1,0.0004631773969430292,6.473890696352274,-7.677400430514807
649,70f,1,0.0004631773969430292,6.47543271670409,-7.677400430514807
650,aiporbitaliptdacryoadenitissialadenitisln,1,0.0004631773969430292,6.476972362889683,-7.677400430514807
651,meningealipt,1,0.0004631773969430292,6.478509642208569,-7.677400430514807
652,66m,1,0.0004631773969430292,6.480044561926653,-7.677400430514807
653,inln,1,0.0004631773969430292,6.481577129276431,-7.677400430514807
654,aipscinln,1,0.0004631773969430292,6.483107351457199,-7.677400430514807
655,74f,1,0.0004631773969430292,6.484635235635252,-7.677400430514807
656,aipsialadenitisln,1,0.0004631773969430292,6.486160788944089,-7.677400430514807
657,ankylosingspondylarthritis,1,0.0004631773969430292,6.48768401848461,-7.677400430514807
658,45m,1,0.0004631773969430292,6.489204931325317,-7.677400430514807
659,aipscsialadenitisinlnaortitis,1,0.0004631773969430292,6.490723534502507,-7.677400430514807
660,rpfmediastinalandpleuralfibrosisriedelthyroiditis,1,0.0004631773969430292,6.492239835020471,-7.677400430514807
661,aortitiscoronaryinflammatorylesions,1,0.0004631773969430292,6.493753839851686,-7.677400430514807
662,53f,1,0.0004631773969430292,6.495265555937008,-7.677400430514807
663,aipsc,1,0.0004631773969430292,6.4967749901858625,-7.677400430514807
664,61m,1,0.0004631773969430292,6.498282149476434,-7.677400430514807
665,rpfaipsialadenitisln,1,0.0004631773969430292,6.499787040655854,-7.677400430514807
666,24f,1,0.0004631773969430292,6.501289670540389,-7.677400430514807
667,sclnsplenomegaly,1,0.0004631773969430292,6.502790045915623,-7.677400430514807
668,56m,1,0.0004631773969430292,6.504288173536645,-7.677400430514807
669,inadpinterstitialpneumonitis,1,0.0004631773969430292,6.505784060128229,-7.677400430514807
670,83m,1,0.0004631773969430292,6.507277712385012,-7.677400430514807
671,inrpfaipsialadenitislnsplenomegaly,1,0.0004631773969430292,6.508769136971682,-7.677400430514807
672,26m,1,0.0004631773969430292,6.51025834052315,-7.677400430514807
673,sialadenitisaipscln,1,0.0004631773969430292,6.511745329644728,-7.677400430514807
674,79f,1,0.0004631773969430292,6.513230110912307,-7.677400430514807
675,aiplninterstitialpneumonitis,1,0.0004631773969430292,6.51471269087253,-7.677400430514807
676,50m,1,0.0004631773969430292,6.516193076042964,-7.677400430514807
677,insialadenitislnhypophysitis,1,0.0004631773969430292,6.517671272912275,-7.677400430514807
678,rpfaortitisdacryoadenitissialadenitisln,1,0.0004631773969430292,6.519147287940395,-7.677400430514807
679,rheumatoidarthritis,1,0.0004631773969430292,6.520621127558696,-7.677400430514807
680,rpfaortitisiliaccarotidandintracerebralinflammatory,1,0.0004631773969430292,6.522092798170152,-7.677400430514807
681,aneurysmshypophysitis,1,0.0004631773969430292,6.523562306149512,-7.677400430514807
682,49m,1,0.0004631773969430292,6.525029657843462,-7.677400430514807
683,aipsclnrenalipt,1,0.0004631773969430292,6.52649485957079,-7.677400430514807
684,41m,1,0.0004631773969430292,6.52795791762255,-7.677400430514807
685,dacryoadenitissialadenitislninterstitialpneumonitis,1,0.0004631773969430292,6.529418838262226,-7.677400430514807
686,rectocolitis,1,0.0004631773969430292,6.530877627725885,-7.677400430514807
687,55m,1,0.0004631773969430292,6.532334292222349,-7.677400430514807
688,aipscrpfaortitissialadenitisrenaliptln,1,0.0004631773969430292,6.5337888379333435,-7.677400430514807
689,anteriorgranulomatousuveitis,1,0.0004631773969430292,6.535241271013659,-7.677400430514807
690,77m,1,0.0004631773969430292,6.536691597591305,-7.677400430514807
691,sialadenitisinpararenalipt,1,0.0004631773969430292,6.53813982376767,-7.677400430514807
692,abbreviationsaipautoimmunepancreatitisininterstitialnephritisiptinflammatorypseudotumorlnlymphnodeinvolvementrpf,1,0.0004631773969430292,6.539585955617669,-7.677400430514807
693,retroperitonealfibrosisscsclerosingcholangitis,1,0.0004631773969430292,6.541029999189903,-7.677400430514807
694,allergicmanifestationswereallergicrhinitisandorbronchialasthma,1,0.0004631773969430292,6.542471960506805,-7.677400430514807
695,51,1,0.0004631773969430292,6.543911845564792,-7.677400430514807
696,polychondritis,1,0.0004631773969430292,6.54534966033442,-7.677400430514807
697,membranous,1,0.0004631773969430292,6.546785410760524,-7.677400430514807
698,glomerulonephritis,1,0.0004631773969430292,6.548219102762372,-7.677400430514807
699,henochschonlein,1,0.0004631773969430292,6.54965074223381,-7.677400430514807
700,purpura,1,0.0004631773969430292,6.551080335043404,-7.677400430514807
701,cystic,1,0.0004631773969430292,6.55250788703459,-7.677400430514807
702,hypogammaglobulinemia,1,0.0004631773969430292,6.553933404025811,-7.677400430514807
703,withrecurrentinfectionsandscleritiseosinophilicfasciitisand,1,0.0004631773969430292,6.555356891810665,-7.677400430514807
704,post-streptococcaluveitisintheother6patientsofnote3of,1,0.0004631773969430292,6.556778356158042,-7.677400430514807
705,plasmocyte,1,0.0004631773969430292,6.558197802812269,-7.677400430514807
706,inthestudygroupthemaletofemaleratiowas261the,1,0.0004631773969430292,6.559615237493242,-7.677400430514807
707,age,1,0.0004631773969430292,6.561030665896573,-7.677400430514807
708,onset,1,0.0004631773969430292,6.56244409369372,-7.677400430514807
709,58,1,0.0004631773969430292,6.5638555265321274,-7.677400430514807
710,24y83,1,0.0004631773969430292,6.565264970035361,-7.677400430514807
711,yr,1,0.0004631773969430292,6.566672429803241,-7.677400430514807
712,delaytodiagnosiscorrespondingtothedelaybetweenthefirst,1,0.0004631773969430292,6.568077911411976,-7.677400430514807
713,symptoms,1,0.0004631773969430292,6.569481420414296,-7.677400430514807
714,discovery,1,0.0004631773969430292,6.570882962339584,-7.677400430514807
715,38,1,0.0004631773969430292,6.5722825426940075,-7.677400430514807
716,delay,1,0.0004631773969430292,6.573680166960646,-7.677400430514807
717,long,1,0.0004631773969430292,6.57507584059962,-7.677400430514807
718,history,1,0.0004631773969430292,6.576469569048224,-7.677400430514807
719,ankylosing,1,0.0004631773969430292,6.577861357721047,-7.677400430514807
720,spondylarthritis,1,0.0004631773969430292,6.579251212010101,-7.677400430514807
721,rheumatoid,1,0.0004631773969430292,6.580639137284949,-7.677400430514807
722,arthritis,1,0.0004631773969430292,6.582025138892826,-7.677400430514807
723,1withrectocolitis,1,0.0004631773969430292,6.583409222158765,-7.677400430514807
724,clinicalfeatures,1,0.0004631773969430292,6.584791392385716,-7.677400430514807
725,andorganinvolvement,1,0.0004631773969430292,6.586171654854675,-7.677400430514807
726,theclinicalfeaturesofpatientsatpresentationarereported,1,0.0004631773969430292,6.587550014824796,-7.677400430514807
727,figure1,1,0.0004631773969430292,6.588926477533519,-7.677400430514807
728,distributionofiggsubclasslevelsinpatientswith,1,0.0004631773969430292,6.590301048196686,-7.677400430514807
729,intable1themostfrequentsymptomswereasthenia56,1,0.0004631773969430292,6.591673732008658,-7.677400430514807
730,igg4-rsdthehorizontalbarsshowthegeometricalmeanand,1,0.0004631773969430292,6.593044534142437,-7.677400430514807
731,weightloss44abdominalpain40siccasyndrome32,1,0.0004631773969430292,6.594413459749778,-7.677400430514807
732,95confidenceinterval,1,0.0004631773969430292,6.595780513961311,-7.677400430514807
733,respectively,1,0.0004631773969430292,6.597145701886651,-7.677400430514807
734,cough,1,0.0004631773969430292,6.598509028614515,-7.677400430514807
735,dyspnea,1,0.0004631773969430292,6.5998704992128365,-7.677400430514807
736,uncommon,1,0.0004631773969430292,6.601230118728877,-7.677400430514807
737,mentofmorethan1organrange2y7organstable3the3,1,0.0004631773969430292,6.602587892189336,-7.677400430514807
738,isolated,1,0.0004631773969430292,6.6039438246004725,-7.677400430514807
739,retropatientspresentedwithtypicalorganinvolvementasshownin,1,0.0004631773969430292,6.6052979209482015,-7.677400430514807
740,peritonealfibrosisn2ormeningealpseudotumorn1,1,0.0004631773969430292,6.606650186198215,-7.677400430514807
741,table2themostcommontissuesinvolvedwerelymphnodes,1,0.0004631773969430292,6.608000625296087,-7.677400430514807
742,glands,1,0.0004631773969430292,6.60934924316738,-7.677400430514807
743,laboratorycharacteristics,1,0.0004631773969430292,6.610696044717759,-7.677400430514807
744,biliary,1,0.0004631773969430292,6.612041034833092,-7.677400430514807
745,duct,1,0.0004631773969430292,6.61338421837956,-7.677400430514807
746,retroperitoneum,1,0.0004631773969430292,6.61472560020376,-7.677400430514807
747,table,1,0.0004631773969430292,6.616065185132817,-7.677400430514807
748,24patientspresentedwitharterialwallinflammatorylesions,1,0.0004631773969430292,6.617402977974478,-7.677400430514807
749,agraphicrepresentationisshowninfigure1igg4geometrical,1,0.0004631773969430292,6.618738983517219,-7.677400430514807
750,all6hadaortitisassociatedin1casewithcoronaryinflammameanlevelwas72sd33glrange14y637glelevenof,1,0.0004631773969430292,6.620073206530356,-7.677400430514807
751,tory,1,0.0004631773969430292,6.621405651764134,-7.677400430514807
752,casewith,1,0.0004631773969430292,6.62273632394984,-7.677400430514807
753,carotid,1,0.0004631773969430292,6.6240652277998935,-7.677400430514807
754,intracerebral,1,0.0004631773969430292,6.625392368007956,-7.677400430514807
755,inflammatoryaneurysmsmostpatientspresentedwithinvolve24,1,0.0004631773969430292,6.626717749249025,-7.677400430514807
756,9114,1,0.0004631773969430292,6.628041376179533,-7.677400430514807
757,122y367,1,0.0004631773969430292,6.6293632534374485,-7.677400430514807
758,964,1,0.0004631773969430292,6.630683385642372,-7.677400430514807
759,731y395,1,0.0004631773969430292,6.63200177739563,-7.677400430514807
760,911,1,0.0004631773969430292,6.633318433280377,-7.677400430514807
761,range113y195glonly3patientspresentedwithalligg,1,0.0004631773969430292,6.634633357861686,-7.677400430514807
762,table4,1,0.0004631773969430292,6.635946555686647,-7.677400430514807
763,laboratorycharacteristicsofpatientswith,1,0.0004631773969430292,6.637258031284457,-7.677400430514807
764,assoigg4-rsd,1,0.0004631773969430292,6.638567789166521,-7.677400430514807
765,ciatedsarcoidosishadonlymildigg1elevatedlevels145gl,1,0.0004631773969430292,6.639875833826536,-7.677400430514807
766,levelsanalysis,1,0.0004631773969430292,6.641182169740591,-7.677400430514807
767,058,1,0.0004631773969430292,6.642486801367256,-7.677400430514807
768,036,1,0.0004631773969430292,6.643789733147672,-7.677400430514807
769,correlationwithigg3levelsp003r043polyclonalhyperigggl,1,0.0004631773969430292,6.645090969505644,-7.677400430514807
770,25518,1,0.0004631773969430292,6.646390514847729,-7.677400430514807
771,gammaglobulinemia,1,0.0004631773969430292,6.647688373563329,-7.677400430514807
772,standard,1,0.0004631773969430292,6.648984550024776,-7.677400430514807
773,protein,1,0.0004631773969430292,6.650279048587422,-7.677400430514807
774,electrophoresis,1,0.0004631773969430292,6.651571873589727,-7.677400430514807
775,igg4gl,1,0.0004631773969430292,6.652863029353347,-7.677400430514807
776,7233,1,0.0004631773969430292,6.654152520183219,-7.677400430514807
777,wasnoticedin802025andhyperproteinemia980glin,1,0.0004631773969430292,6.655440350367647,-7.677400430514807
778,igg1gl,1,0.0004631773969430292,6.656726524178391,-7.677400430514807
779,12118,1,0.0004631773969430292,6.658011045870748,-7.677400430514807
780,48,1,0.0004631773969430292,6.659293919683638,-7.677400430514807
781,1225,1,0.0004631773969430292,6.660575149839686,-7.677400430514807
782,ige,1,0.0004631773969430292,6.661854740545311,-7.677400430514807
783,igg2gl,1,0.0004631773969430292,6.663132695990803,-7.677400430514807
784,4024,1,0.0004631773969430292,6.664409020350408,-7.677400430514807
785,antibodies,1,0.0004631773969430292,6.665683717782408,-7.677400430514807
786,diluigg3gl,1,0.0004631773969430292,6.666956792429207,-7.677400430514807
787,1132,1,0.0004631773969430292,6.668228248417403,-7.677400430514807
788,tionsover1100in4of25patientsnoneofthe23patientsexlowch50,1,0.0004631773969430292,6.669498089857879,-7.677400430514807
789,33515,1,0.0004631773969430292,6.670766320845874,-7.677400430514807
790,aminedhadanti-ssaoranti-ssbantibodieselevatedc-reactive,1,0.0004631773969430292,6.672032945461067,-7.677400430514807
791,lowc3,1,0.0004631773969430292,6.673297967767654,-7.677400430514807
792,44716,1,0.0004631773969430292,6.674561391814426,-7.677400430514807
793,proteinlevels910mglwereobservedin56withameanof,1,0.0004631773969430292,6.675823221634848,-7.677400430514807
794,lowc4,1,0.0004631773969430292,6.677083461247136,-7.677400430514807
795,40615,1,0.0004631773969430292,6.678342114654332,-7.677400430514807
796,3089,1,0.0004631773969430292,6.679599185844383,-7.677400430514807
797,11y148,1,0.0004631773969430292,6.680854678790215,-7.677400430514807
798,c3,1,0.0004631773969430292,6.682108597449809,-7.677400430514807
799,c4,1,0.0004631773969430292,6.683360945766275,-7.677400430514807
800,ana,1,0.0004631773969430292,6.684611727667927,-7.677400430514807
801,16425,1,0.0004631773969430292,6.68586094706836,-7.677400430514807
802,fraction,1,0.0004631773969430292,6.687108607866515,-7.677400430514807
803,decreased,1,0.0004631773969430292,6.688354713946762,-7.677400430514807
804,a-ssa,1,0.0004631773969430292,6.6895992691789665,-7.677400430514807
805,patientsofthese7hadnephritis,1,0.0004631773969430292,6.690842277418564,-7.677400430514807
806,a-ssb,1,0.0004631773969430292,6.692083742506628,-7.677400430514807
807,histologicfindings,1,0.0004631773969430292,6.693323668269949,-7.677400430514807
808,elevatedige9100kuil,1,0.0004631773969430292,6.694562058521095,-7.677400430514807
809,4025,1,0.0004631773969430292,6.695798917058491,-7.677400430514807
810,elevatedcrp910mgl,1,0.0004631773969430292,6.697034247666484,-7.677400430514807
811,561425,1,0.0004631773969430292,6.698268054115413,-7.677400430514807
812,wasperformedrange1y4differenttissuebiopsiesperpatient,1,0.0004631773969430292,6.699500340161678,-7.677400430514807
813,abbreviationsanaantinuclearantibodiesa-ssaanti-ss-aro,1,0.0004631773969430292,6.70073110954781,-7.677400430514807
814,resultsofconventionalhistologicexaminationonhematoxylinantibodiesa-ssbanti-ss-blaantibodiesch5050hemolyticunit,1,0.0004631773969430292,6.70196036600254,-7.677400430514807
815,eosin,1,0.0004631773969430292,6.703188113240863,-7.677400430514807
816,ofcomplementcrpc-reactiveprotein,1,0.0004631773969430292,6.704414354964107,-7.677400430514807
817,immunohistochemical,1,0.0004631773969430292,6.705639094860003,-7.677400430514807
818,valuesareprovidedasgeometricalmeansgeometricalsdforigg,1,0.0004631773969430292,6.706862336602747,-7.677400430514807
819,withanti-igg4mabwasperformedinonly12patientstable5,1,0.0004631773969430292,6.70808408385307,-7.677400430514807
820,igg1igg2igg3andigg4incidenceratesnumbersofpositivepatients,1,0.0004631773969430292,6.709304340258298,-7.677400430514807
821,depicts,1,0.0004631773969430292,6.710523109452428,-7.677400430514807
822,areshownforanaa-ssaa-ssbelevatedigeelevatedcrpandlow,1,0.0004631773969430292,6.71174039505618,-7.677400430514807
823,ch50c3andc4igea-ssaa-ssbandch50c3c4wereexamined,1,0.0004631773969430292,6.71295620067707,-7.677400430514807
824,in52323and151615patientsrespectivelynotall,1,0.0004631773969430292,6.714170529909472,-7.677400430514807
825,patientsfibrosiswasnoticedin80andextranodallymphoid,1,0.0004631773969430292,6.715383386334681,-7.677400430514807
826,table5,1,0.0004631773969430292,6.716594773520978,-7.677400430514807
827,histologicresultsfor25igg4-rsdpatients,1,0.0004631773969430292,6.717804695023691,-7.677400430514807
828,lg,1,0.0004631773969430292,6.71901315438526,-7.677400430514807
829,noigg4plasmacell,1,0.0004631773969430292,6.720220155135295,-7.677400430514807
830,nopredominantigg4expression,1,0.0004631773969430292,6.721425700790643,-7.677400430514807
831,pleura,1,0.0004631773969430292,6.7226297948554485,-7.677400430514807
832,thyroid,1,0.0004631773969430292,6.723832440821209,-7.677400430514807
833,aorticwall,1,0.0004631773969430292,6.725033642166843,-7.677400430514807
834,ef,1,0.0004631773969430292,6.726233402358747,-7.677400430514807
835,igg4stainingbutnoigg4plasmacells,1,0.0004631773969430292,6.727431724850855,-7.677400430514807
836,igaplasmacellsigmplasmacells,1,0.0004631773969430292,6.728628613084702,-7.677400430514807
837,frp,1,0.0004631773969430292,6.729824070489475,-7.677400430514807
838,9150hpf,1,0.0004631773969430292,6.731018100482083,-7.677400430514807
839,igg4plasmacells60,1,0.0004631773969430292,6.732210706467206,-7.677400430514807
840,igg4plasmacellsandigaplasmacells,1,0.0004631773969430292,6.733401891837359,-7.677400430514807
841,continuedonnextpage,1,0.0004631773969430292,6.734591659972948,-7.677400430514807
842,53,1,0.0004631773969430292,6.7357800142423265,-7.677400430514807
843,table5continued,1,0.0004631773969430292,6.736966958001855,-7.677400430514807
844,bronchial,1,0.0004631773969430292,6.738152494595957,-7.677400430514807
845,mucosa,1,0.0004631773969430292,6.739336627357174,-7.677400430514807
846,stomach,1,0.0004631773969430292,6.740519359606223,-7.677400430514807
847,ileum,1,0.0004631773969430292,6.741700694652055,-7.677400430514807
848,colon,1,0.0004631773969430292,6.742880635791903,-7.677400430514807
849,pararenalipt,1,0.0004631773969430292,6.744059186311348,-7.677400430514807
850,abbreviationsefepithelioidfolliclesfhfollicularhyperplasiahpfhigh-powerfieldifinterfollicularinfiltrationiptinflammatory,1,0.0004631773969430292,6.745236349484363,-7.677400430514807
851,pseudotumorlglachrimalglandlnlymphadenopathynpatientnumbernadatanotavailablerpfretroperitonealfibrosissgsalivary,1,0.0004631773969430292,6.7464121285733745,-7.677400430514807
852,gland,1,0.0004631773969430292,6.747586526829315,-7.677400430514807
853,scalenonotpresentpresentabundantorintense,1,0.0004631773969430292,6.748759547491679,-7.677400430514807
854,in52ofpatients,1,0.0004631773969430292,6.74993119378857,-7.677400430514807
855,thedegree,1,0.0004631773969430292,6.75110146893676,-7.677400430514807
856,ofthese,1,0.0004631773969430292,6.752270376141742,-7.677400430514807
857,his-,1,0.0004631773969430292,6.75343791859778,-7.677400430514807
858,biopsy,1,0.0004631773969430292,6.754604099487962,-7.677400430514807
859,tologicchangeswasvariableinthesamepatientdependingon,1,0.0004631773969430292,6.755768921984255,-7.677400430514807
860,igg4andigg3plasmacellsbonemarrowbiopsywaspertheorgananalyzedstainingwith,1,0.0004631773969430292,6.756932389247553,-7.677400430514807
861,ananti-igg4mabontissue,1,0.0004631773969430292,6.7580945044277305,-7.677400430514807
862,formedin13patientsandwasnormalin754in2patients,1,0.0004631773969430292,6.759255270663693,-7.677400430514807
863,sections,1,0.0004631773969430292,6.760414691083428,-7.677400430514807
864,apolyclonalmaturelymphocyticinfiltrationwasobservedand,1,0.0004631773969430292,6.761572768804055,-7.677400430514807
865,polyclonalplasmacellinfiltrationwasnotedin6patientsbutno,1,0.0004631773969430292,6.762729506931879,-7.677400430514807
866,detected,1,0.0004631773969430292,6.763884908562435,-7.677400430514807
867,predominate,1,0.0004631773969430292,6.7650389767805414,-7.677400430514807
868,igg4stainingwasavailable,1,0.0004631773969430292,6.7661917146603505,-7.677400430514807
869,iggplasmacellsinanotherpatientthesalivaryglandlacked,1,0.0004631773969430292,6.767343125265392,-7.677400430514807
870,igg4plasmacellspatient18inpatient18whopresented,1,0.0004631773969430292,6.76849321164863,-7.677400430514807
871,follow-upandresponsetotreatment,1,0.0004631773969430292,6.769641976852503,-7.677400430514807
872,withtypicalrenalinterstitiallymphoidandplasmacellinfiltra-,1,0.0004631773969430292,6.77078942390898,-7.677400430514807
873,patientfollow-upandhistorieswererecordedwithamean,1,0.0004631773969430292,6.771935555839602,-7.677400430514807
874,tion,1,0.0004631773969430292,6.773080375655535,-7.677400430514807
875,extensive,1,0.0004631773969430292,6.774223886357614,-7.677400430514807
876,604,1,0.0004631773969430292,6.775366090936392,-7.677400430514807
877,months,1,0.0004631773969430292,6.776506992372183,-7.677400430514807
878,4y224,1,0.0004631773969430292,6.777646593635117,-7.677400430514807
879,mo,1,0.0004631773969430292,6.778784897685177,-7.677400430514807
880,werenotdetecteddespiteserumigg4throughlevelsof206gl,1,0.0004631773969430292,6.779921907472252,-7.677400430514807
881,died,1,0.0004631773969430292,6.78105762593618,-7.677400430514807
882,probable,1,0.0004631773969430292,6.782192056006791,-7.677400430514807
883,rupture,1,0.0004631773969430292,6.78332520060396,-7.677400430514807
884,thoracic,1,0.0004631773969430292,6.784457062637643,-7.677400430514807
885,aortic,1,0.0004631773969430292,6.785587645007929,-7.677400430514807
886,inthispatientfurtherimmunostainingwithanti-igaandanti-,1,0.0004631773969430292,6.786716950605081,-7.677400430514807
887,aneurysmtreatmentsareshownintable6treatmentefficacy,1,0.0004631773969430292,6.787844982309579,-7.677400430514807
888,mabs,1,0.0004631773969430292,6.78897174299217,-7.677400430514807
889,iga,1,0.0004631773969430292,6.790097235513905,-7.677400430514807
890,determined,1,0.0004631773969430292,6.7912214627261855,-7.677400430514807
891,lesser,1,0.0004631773969430292,6.792344427470809,-7.677400430514807
892,extent,1,0.0004631773969430292,6.79346613258001,-7.677400430514807
893,global,1,0.0004631773969430292,6.794586580876499,-7.677400430514807
894,immunoglobulin,1,0.0004631773969430292,6.795705775173514,-7.677400430514807
895,light,1,0.0004631773969430292,6.796823718274855,-7.677400430514807
896,chains,1,0.0004631773969430292,6.79794041297493,-7.677400430514807
897,anti-kappa,1,0.0004631773969430292,6.799055862058796,-7.677400430514807
898,anti-,1,0.0004631773969430292,6.8001700683022,-7.677400430514807
899,received,1,0.0004631773969430292,6.80128303447162,-7.677400430514807
900,median,1,0.0004631773969430292,6.802394763324311,-7.677400430514807
901,06,1,0.0004631773969430292,6.803505257608338,-7.677400430514807
902,lambda,1,0.0004631773969430292,6.804614520062624,-7.677400430514807
903,mab,1,0.0004631773969430292,6.805722553416985,-7.677400430514807
904,bone,1,0.0004631773969430292,6.806829360392176,-7.677400430514807
905,marrow,1,0.0004631773969430292,6.807934943699926,-7.677400430514807
906,067,1,0.0004631773969430292,6.80903930604298,-7.677400430514807
907,sd,1,0.0004631773969430292,6.810142450115136,-7.677400430514807
908,03,1,0.0004631773969430292,6.811244378601294,-7.677400430514807
909,012y1,1,0.0004631773969430292,6.812345094177479,-7.677400430514807
910,biopsywasnormalserumigaandigmlevelswerenormalin,1,0.0004631773969430292,6.813444599510896,-7.677400430514807
911,receive,1,0.0004631773969430292,6.814542897259958,-7.677400430514807
912,consequence,1,0.0004631773969430292,6.815639990074331,-7.677400430514807
913,mild,1,0.0004631773969430292,6.816735880594968,-7.677400430514807
914,thispatientinanotherpatientpatient15withincreasedigg4,1,0.0004631773969430292,6.81783057145415,-7.677400430514807
915,contraindication,1,0.0004631773969430292,6.818924065275521,-7.677400430514807
916,pulmoand,1,0.0004631773969430292,6.82001636467413,-7.677400430514807
917,narytuberculosisundertreatmentandchronicosteitisefficacy,1,0.0004631773969430292,6.821107472256465,-7.677400430514807
918,table6,1,0.0004631773969430292,6.822197390620491,-7.677400430514807
919,treatmentandefficacy,1,0.0004631773969430292,6.823286122355687,-7.677400430514807
920,patientstreated,1,0.0004631773969430292,6.824373670043086,-7.677400430514807
921,treatmenteffective,1,0.0004631773969430292,6.825460036255307,-7.677400430514807
922,sideeffects,1,0.0004631773969430292,6.826545223556594,-7.677400430514807
923,2392,1,0.0004631773969430292,6.827629234502852,-7.677400430514807
924,192190,1,0.0004631773969430292,6.828712071641684,-7.677400430514807
925,142167,1,0.0004631773969430292,6.829793737512425,-7.677400430514807
926,3475,1,0.0004631773969430292,6.8308742346461795,-7.677400430514807
927,2367,1,0.0004631773969430292,6.831953565565855,-7.677400430514807
928,030,1,0.0004631773969430292,6.833031732786201,-7.677400430514807
929,cyclophosphamide,1,0.0004631773969430292,6.834108738813838,-7.677400430514807
930,1250,1,0.0004631773969430292,6.835184586147301,-7.677400430514807
931,surgery,1,0.0004631773969430292,6.836259277277067,-7.677400430514807
932,hepatictransplantation,1,0.0004631773969430292,6.837332814685591,-7.677400430514807
933,vinblastine,1,0.0004631773969430292,6.838405200847344,-7.677400430514807
934,tamoxifen,1,0.0004631773969430292,6.839476438228843,-7.677400430514807
935,tocilizumab,1,0.0004631773969430292,6.840546529288687,-7.677400430514807
936,recenttreatmentfor2patientsresponseandtolerancenotyetevaluable,1,0.0004631773969430292,6.841615476477592,-7.677400430514807
937,54,1,0.0004631773969430292,6.842683282238422,-7.677400430514807
938,wasnoticedin90ofcasescorticosteroidscouldbestopped,1,0.0004631773969430292,6.843749949006225,-7.677400430514807
939,ranging,1,0.0004631773969430292,6.844815479208263,-7.677400430514807
940,637,1,0.0004631773969430292,6.84587987526405,-7.677400430514807
941,remarkably,1,0.0004631773969430292,6.846943139585379,-7.677400430514807
942,30,1,0.0004631773969430292,6.848005274576363,-7.677400430514807
943,treated,1,0.0004631773969430292,6.849066282633458,-7.677400430514807
944,second-line,1,0.0004631773969430292,6.8501261661455,-7.677400430514807
945,werefoundespeciallyinpatientswithinterstitialnephritisthere,1,0.0004631773969430292,6.851184927493743,-7.677400430514807
946,in1248patientsbecauseofsteroiddependenceandorste-,1,0.0004631773969430292,6.852242569051878,-7.677400430514807
947,wasnocorrelationbetweenserumigg4igg1andigg2levels,1,0.0004631773969430292,6.853299093186078,-7.677400430514807
948,roid,1,0.0004631773969430292,6.854354502255021,-7.677400430514807
949,effects,1,0.0004631773969430292,6.855408798609928,-7.677400430514807
950,levelsinonly3casesalliggsubclasseswereincreasedigg4,1,0.0004631773969430292,6.856461984594587,-7.677400430514807
951,estimated,1,0.0004631773969430292,6.85751406254539,-7.677400430514807
952,good,1,0.0004631773969430292,6.858565034791365,-7.677400430514807
953,re-,1,0.0004631773969430292,6.859614903654202,-7.677400430514807
954,andigg3levelsweresignificantlyhigherinigg4-rsdpatients,1,0.0004631773969430292,6.860663671448287,-7.677400430514807
955,sponsein2patients1620andnoresponsein1patient14,1,0.0004631773969430292,6.86171134048073,-7.677400430514807
956,withrenalinvolvementthaninigg4-rsdpatientswithoutrenal,1,0.0004631773969430292,6.862757913051401,-7.677400430514807
957,involvementp00048andp00034respectivelymorearticlebykhosroshahietal10ainthissameissuecyclophos-,1,0.0004631773969430292,6.863803391452954,-7.677400430514807
958,overin7888patientswithinterstitialnephritisc3andor,1,0.0004631773969430292,6.86484777797086,-7.677400430514807
959,phamide,1,0.0004631773969430292,6.8658910748834385,-7.677400430514807
960,c4complementfractionsweredecreasedonly29ofpatients,1,0.0004631773969430292,6.866933284461882,-7.677400430514807
961,in1andtocilizumabin1,1,0.0004631773969430292,6.8679744089702925,-7.677400430514807
962,withoutrenal,1,0.0004631773969430292,6.8690144506657065,-7.677400430514807
963,involvementa,1,0.0004631773969430292,6.870053411798126,-7.677400430514807
964,highfrequencyofhypocomplementemiawas,1,0.0004631773969430292,6.871091294610546,-7.677400430514807
965,tubulointerstitial,1,0.0004631773969430292,6.872128101338986,-7.677400430514807
966,nephritis15asigg4doesnotactivatethecomplementclassical,1,0.0004631773969430292,6.873163834212518,-7.677400430514807
967,discussion,1,0.0004631773969430292,6.874198495453294,-7.677400430514807
968,pathwaythesefindingsmaysuggestthatigg3couldparticipate,1,0.0004631773969430292,6.875232087276577,-7.677400430514807
969,report,1,0.0004631773969430292,6.876264611890766,-7.677400430514807
970,recorded,1,0.0004631773969430292,6.877296071497429,-7.677400430514807
971,inimmunecomplexformation,1,0.0004631773969430292,6.878326468291325,-7.677400430514807
972,frenchnationalregistrytodatenowell-recognizedinternational,1,0.0004631773969430292,6.879355804460439,-7.677400430514807
973,atypical,1,0.0004631773969430292,6.880384082186005,-7.677400430514807
974,defined,1,0.0004631773969430292,6.881411303642535,-7.677400430514807
975,immunohistologydespitetypicalhistologicabnormalitieson,1,0.0004631773969430292,6.882437470997847,-7.677400430514807
976,conventional,1,0.0004631773969430292,6.883462586413092,-7.677400430514807
977,immuwith,1,0.0004631773969430292,6.884486652042782,-7.677400430514807
978,nohistologicanalysisofplasmacellinfiltrationwassurprising,1,0.0004631773969430292,6.885509670034818,-7.677400430514807
979,enables,1,0.0004631773969430292,6.88653164253051,-7.677400430514807
980,distinguished,1,0.0004631773969430292,6.887552571664617,-7.677400430514807
981,well-,1,0.0004631773969430292,6.8885724595653635,-7.677400430514807
982,inpatient15igg4plasmacellswereassociatedwithnumercharacterizedautoimmuneorinflammatorydiseaselymphopro-,1,0.0004631773969430292,6.889591308354466,-7.677400430514807
983,ousigg3plasmacellsinlymphnodeandkidneyinpatient22,1,0.0004631773969430292,6.890609120147166,-7.677400430514807
984,malignant,1,0.0004631773969430292,6.891625897052253,-7.677400430514807
985,diseases,1,0.0004631773969430292,6.892641641172089,-7.677400430514807
986,numerousigaplasmacellswereassociatedwithigg4plasma,1,0.0004631773969430292,6.893656354602635,-7.677400430514807
987,increased,1,0.0004631773969430292,6.894670039433482,-7.677400430514807
988,levels11,1,0.0004631773969430292,6.895682697747868,-7.677400430514807
989,included,1,0.0004631773969430292,6.8966943316227125,-7.677400430514807
990,cellsintherenalinterstitiumandinpatient18onlyigaand,1,0.0004631773969430292,6.897704943128636,-7.677400430514807
991,presenting,1,0.0004631773969430292,6.898714534329988,-7.677400430514807
992,igmplasmacellswerefoundinthekidneytheobservations,1,0.0004631773969430292,6.899723107284872,-7.677400430514807
993,classical,1,0.0004631773969430292,6.900730664045173,-7.677400430514807
994,thatotheriggsubclassesarealsoelevatedinthebloodofmore,1,0.0004631773969430292,6.901737206656574,-7.677400430514807
995,infil-,1,0.0004631773969430292,6.902742737158593,-7.677400430514807
996,thanhalfthepatientsandthatnumerousinfiltratingplasmacells,1,0.0004631773969430292,6.903747257584598,-7.677400430514807
997,trationwithoutevidenceofotherdiseasesofnotenoneofthe,1,0.0004631773969430292,6.904750769961838,-7.677400430514807
998,actually,1,0.0004631773969430292,6.905753276311464,-7.677400430514807
999,express,1,0.0004631773969430292,6.906754778648554,-7.677400430514807
1000,isotypes,1,0.0004631773969430292,6.907755278982137,-7.677400430514807
1001,anti-ssa,1,0.0004631773969430292,6.90875477931522,-7.677400430514807
1002,anti-ssb,1,0.0004631773969430292,6.90975328164481,-7.677400430514807
1003,broadpolyclonalblymphocyteactivationthantheskewedigg4,1,0.0004631773969430292,6.910750787961936,-7.677400430514807
1004,low,1,0.0004631773969430292,6.911747300251674,-7.677400430514807
1005,titers,1,0.0004631773969430292,6.912742820493176,-7.677400430514807
1006,autoantibodies,1,0.0004631773969430292,6.913737350659685,-7.677400430514807
1007,unfortunately,1,0.0004631773969430292,6.914730892718563,-7.677400430514807
1008,switch,1,0.0004631773969430292,6.915723448631314,-7.677400430514807
1009,retrospective,1,0.0004631773969430292,6.9167150203536085,-7.677400430514807
1010,multicentric,1,0.0004631773969430292,6.917705609835305,-7.677400430514807
1011,analyzedinthecurrentstudywithananti-igg4mabshowed,1,0.0004631773969430292,6.918695219020472,-7.677400430514807
1012,lacking,1,0.0004631773969430292,6.919683849847411,-7.677400430514807
1013,significant,1,0.0004631773969430292,6.920671504248683,-7.677400430514807
1014,abundantigg4plasmacells812thesefindingsconfirmthe,1,0.0004631773969430292,6.921658184151129,-7.677400430514807
1015,number,1,0.0004631773969430292,6.922643891475888,-7.677400430514807
1016,accurate,1,0.0004631773969430292,6.923628628138427,-7.677400430514807
1017,importanceofcharacterizingalltheimmunoglobulinisotypesof,1,0.0004631773969430292,6.92461239604856,-7.677400430514807
1018,quantitativeanalysisforigg4plasmocyteinfiltrationwasavail-,1,0.0004631773969430292,6.925595197110468,-7.677400430514807
1019,theplasmacellinfiltrationinigg4-rsdtoclarifytheseobserable,1,0.0004631773969430292,6.926577033222725,-7.677400430514807
1020,satisfied,1,0.0004631773969430292,6.927557906278317,-7.677400430514807
1021,clini-,1,0.0004631773969430292,6.928537818164665,-7.677400430514807
1022,vationsandthenatureofplasmocyteinfiltrationinigg4-rsd,1,0.0004631773969430292,6.92951677076365,-7.677400430514807
1023,cal,1,0.0004631773969430292,6.930494765951626,-7.677400430514807
1024,recently,1,0.0004631773969430292,6.931471805599453,-7.677400430514807
1025,proposed13,1,0.0004631773969430292,6.932447891572509,-7.677400430514807
1026,fivepatientswereexcludedfromthecurrentseriesbecause,1,0.0004631773969430292,6.933423025730715,-7.677400430514807
1027,find-,1,0.0004631773969430292,6.934397209928558,-7.677400430514807
1028,lack,1,0.0004631773969430292,6.93537044601511,-7.677400430514807
1029,ingswitheitherpolyclonalplasmacellandorlymphocyticinfil-,1,0.0004631773969430292,6.9363427358340495,-7.677400430514807
1030,igg4levelsandtypicalorganinvolvementpathologicfeatures,1,0.0004631773969430292,6.937314081223682,-7.677400430514807
1031,tration100orstoriformfibrosis80,1,0.0004631773969430292,6.93828448401696,-7.677400430514807
1032,degree,1,0.0004631773969430292,6.939253946041508,-7.677400430514807
1033,presence,1,0.0004631773969430292,6.940222469119639,-7.677400430514807
1034,males,1,0.0004631773969430292,6.9411900550683745,-7.677400430514807
1035,lymphocyticandplasmacellinfiltrationandfibrosiscouldvary,1,0.0004631773969430292,6.942156705699469,-7.677400430514807
1036,conditionswere,1,0.0004631773969430292,6.943122422819428,-7.677400430514807
1037,noticed,1,0.0004631773969430292,6.9440872082295275,-7.677400430514807
1038,inonlya,1,0.0004631773969430292,6.945051063725834,-7.677400430514807
1039,withinthesamepatientdependingonthetissueanalyzedthe,1,0.0004631773969430292,6.946013991099227,-7.677400430514807
1040,fewof,1,0.0004631773969430292,6.946975992135418,-7.677400430514807
1041,frequencyinsome,1,0.0004631773969430292,6.947937068614969,-7.677400430514807
1042,usualabsenceoffibrosisinlymphnodeswasnotsurprisingand,1,0.0004631773969430292,6.948897222313312,-7.677400430514807
1043,cohorts11,1,0.0004631773969430292,6.949856455000773,-7.677400430514807
1044,enlargement,1,0.0004631773969430292,6.950814768442584,-7.677400430514807
1045,accordance,1,0.0004631773969430292,6.951772164398911,-7.677400430514807
1046,premostfrequentsignwhich,1,0.0004631773969430292,6.952728644624869,-7.677400430514807
1047,mightsuggestaprimarydefectthat,1,0.0004631773969430292,6.953684210870537,-7.677400430514807
1048,sented,1,0.0004631773969430292,6.954638864880987,-7.677400430514807
1049,couldinvolvesecondarylymphoidevents,1,0.0004631773969430292,6.955592608396297,-7.677400430514807
1050,pathologicfeaturesincludingigg4plasmacellinfiltrationbut,1,0.0004631773969430292,6.956545443151569,-7.677400430514807
1051,exthanexpectedconsideringthefrequencyofsialadenitis4411,1,0.0004631773969430292,6.957497370876951,-7.677400430514807
1052,cludedfromthestudybutraisethequestionoftheimportance,1,0.0004631773969430292,6.9584483932976555,-7.677400430514807
1053,mostpatientspresentedwithmultipleorganinvolvementorgan,1,0.0004631773969430292,6.959398512133975,-7.677400430514807
1054,accorded,1,0.0004631773969430292,6.960347729101308,-7.677400430514807
1055,involvementinthecurrentseriesisinaccordancewithprevious,1,0.0004631773969430292,6.961296045910167,-7.677400430514807
1056,ofigg4-rsdinfactthesepatientsprobablypresentedwitha,1,0.0004631773969430292,6.962243464266207,-7.677400430514807
1057,seronegativeigg4-rsdasproposedintheclinicaldiagnosglands44involvementasthemostfrequentmanifestations,1,0.0004631773969430292,6.963189985870238,-7.677400430514807
1058,tic,1,0.0004631773969430292,6.964135612418245,-7.677400430514807
1059,japanese,1,0.0004631773969430292,6.9650803456014065,-7.677400430514807
1060,research,1,0.0004631773969430292,6.966024187106113,-7.677400430514807
1061,inthecurrentstudyrenalinvolvementwasrelativelymorefre-,1,0.0004631773969430292,6.966967138613983,-7.677400430514807
1062,committeeforsystemicigg4-relatedsclerosingdisease13,1,0.0004631773969430292,6.967909201801884,-7.677400430514807
1063,quent,1,0.0004631773969430292,6.968850378341948,-7.677400430514807
1064,1711,1,0.0004631773969430292,6.96979066990159,-7.677400430514807
1065,thecurrentretrospectiveanalysisofresponsetotreatment,1,0.0004631773969430292,6.970730078143525,-7.677400430514807
1066,basic,1,0.0004631773969430292,6.97166860472579,-7.677400430514807
1067,differences,1,0.0004631773969430292,6.9726062513017535,-7.677400430514807
1068,maybe,1,0.0004631773969430292,6.97354301952014,-7.677400430514807
1069,related,1,0.0004631773969430292,6.974478911025045,-7.677400430514807
1070,tothepatientsrecruitment,1,0.0004631773969430292,6.975413927455952,-7.677400430514807
1071,criteriathatdidnotallowstrongconclusionsweobservedthe,1,0.0004631773969430292,6.976348070447749,-7.677400430514807
1072,account,1,0.0004631773969430292,6.977281341630747,-7.677400430514807
1073,igg4-,1,0.0004631773969430292,6.9782137426306985,-7.677400430514807
1074,efficacy,1,0.0004631773969430292,6.97914527506881,-7.677400430514807
1075,rsdisunder-recognizedandthatpatientsincludedinthereg-,1,0.0004631773969430292,6.980075940561763,-7.677400430514807
1076,second-,1,0.0004631773969430292,6.98100574072173,-7.677400430514807
1077,third-line,1,0.0004631773969430292,6.981934677156389,-7.677400430514807
1078,indicates,1,0.0004631773969430292,6.982862751468942,-7.677400430514807
1079,istryarethoseprobablypresentingwithaseverediseasewhich,1,0.0004631773969430292,6.983789965258135,-7.677400430514807
1080,urgent,1,0.0004631773969430292,6.984716320118266,-7.677400430514807
1081,understanding,1,0.0004631773969430292,6.985641817639208,-7.677400430514807
1082,mayaccountforthehighfrequencyofmultipleorganinvolve-,1,0.0004631773969430292,6.9865664594064265,-7.677400430514807
1083,help,1,0.0004631773969430292,6.9874902470009905,-7.677400430514807
1084,new,1,0.0004631773969430292,6.988413181999592,-7.677400430514807
1085,specific,1,0.0004631773969430292,6.98933526597456,-7.677400430514807
1086,therament,1,0.0004631773969430292,6.990256500493881,-7.677400430514807
1087,aortitis,1,0.0004631773969430292,6.99117688712121,-7.677400430514807
1088,as-,1,0.0004631773969430292,6.992096427415888,-7.677400430514807
1089,peutic,1,0.0004631773969430292,6.9930151229329605,-7.677400430514807
1090,strategies,1,0.0004631773969430292,6.993932975223189,-7.677400430514807
1091,importantly,1,0.0004631773969430292,6.994849985833071,-7.677400430514807
1092,sociated,1,0.0004631773969430292,6.9957661563048505,-7.677400430514807
1093,otherarterialinflammatorylesions,1,0.0004631773969430292,6.996681488176539,-7.677400430514807
1094,in2ofthem,1,0.0004631773969430292,6.9975959829819265,-7.677400430514807
1095,igg4-secreting,1,0.0004631773969430292,6.9985096422506015,-7.677400430514807
1096,merely,1,0.0004631773969430292,6.999422467507961,-7.677400430514807
1097,result,1,0.0004631773969430292,7.00033446027523,-7.677400430514807
1098,upstream,1,0.0004631773969430292,7.001245622069476,-7.677400430514807
1099,confirms,1,0.0004631773969430292,7.002155954403621,-7.677400430514807
1100,large-vessel,1,0.0004631773969430292,7.003065458786462,-7.677400430514807
1101,pathogenic,1,0.0004631773969430292,7.00397413672268,-7.677400430514807
1102,immunologic,1,0.0004631773969430292,7.004881989712859,-7.677400430514807
1103,eventor,1,0.0004631773969430292,7.005789019253503,-7.677400430514807
1104,theydo,1,0.0004631773969430292,7.00669522683704,-7.677400430514807
1105,participate,1,0.0004631773969430292,7.007600613951853,-7.677400430514807
1106,vasculitisasrecentlyreported101718,1,0.0004631773969430292,7.00850518208228,-7.677400430514807
1107,direct,1,0.0004631773969430292,7.009408932708637,-7.677400430514807
1108,indirect,1,0.0004631773969430292,7.010311867307229,-7.677400430514807
1109,imlaboratoryfindingsfor,1,0.0004631773969430292,7.011213987350367,-7.677400430514807
1110,patientsinthecurrentstudywere,1,0.0004631773969430292,7.01211529430638,-7.677400430514807
1111,plication,1,0.0004631773969430292,7.01301578963963,-7.677400430514807
1112,classes,1,0.0004631773969430292,7.013915474810528,-7.677400430514807
1113,comparabletothosereportedpreviouslyinpatientswithigg4-,1,0.0004631773969430292,7.014814351275545,-7.677400430514807
1114,modifications,1,0.0004631773969430292,7.01571242048723,-7.677400430514807
1115,rsd,1,0.0004631773969430292,7.016609683894219,-7.677400430514807
1116,extremely,1,0.0004631773969430292,7.017506142941256,-7.677400430514807
1117,variable,1,0.0004631773969430292,7.018401799069201,-7.677400430514807
1118,subsetsinigg4-rsd4thelper2th2andregulatorytcells,1,0.0004631773969430292,7.0192966537150445,-7.677400430514807
1119,55,1,0.0004631773969430292,7.020190708311925,-7.677400430514807
1120,demonstrated,1,0.0004631773969430292,7.02108396428914,-7.677400430514807
1121,10akhosroshahiacarruthersmndeshpandevunizonys,1,0.0004631773969430292,7.02197642307216,-7.677400430514807
1122,patients32021,1,0.0004631773969430292,7.022868086082641,-7.677400430514807
1123,subsets,1,0.0004631773969430292,7.023758954738443,-7.677400430514807
1124,follicular,1,0.0004631773969430292,7.024649030453636,-7.677400430514807
1125,blochdbstonejhrituximabforthetreatmentofigg4-related,1,0.0004631773969430292,7.025538314638521,-7.677400430514807
1126,helpertcellsmaycertainlyparticipate,1,0.0004631773969430292,7.026426808699636,-7.677400430514807
1127,inthepathogenesisof,1,0.0004631773969430292,7.027314514039777,-7.677400430514807
1128,diseaselessonsfrom10consecutivepatientsmedicinebaltimore,1,0.0004631773969430292,7.028201432058005,-7.677400430514807
1129,enhancing,1,0.0004631773969430292,7.029087564149662,-7.677400430514807
1130,isotype,1,0.0004631773969430292,7.029972911706386,-7.677400430514807
1131,switching,1,0.0004631773969430292,7.030857476116121,-7.677400430514807
1132,b-cell,1,0.0004631773969430292,7.0317412587631285,-7.677400430514807
1133,ter-,1,0.0004631773969430292,7.0326242610280065,-7.677400430514807
1134,20129157y66,1,0.0004631773969430292,7.033506484287697,-7.677400430514807
1135,minaldifferentiationfurtherclinicallaboratoryandhistologic,1,0.0004631773969430292,7.034387929915503,-7.677400430514807
1136,masakiydonglkurosenkitagawakmorikawayyamamotom,1,0.0004631773969430292,7.035268599281097,-7.677400430514807
1137,needed,1,0.0004631773969430292,7.036148493750536,-7.677400430514807
1138,tovalidate,1,0.0004631773969430292,7.037027614686276,-7.677400430514807
1139,takahashihshinomurayimaiksaekitazumianakadas,1,0.0004631773969430292,7.037905963447182,-7.677400430514807
1140,diagnosticcriteria,1,0.0004631773969430292,7.038783541388542,-7.677400430514807
1141,sugiyamaematsuisoriguchitnishiyamasnishimoriinojimat,1,0.0004631773969430292,7.039660349862076,-7.677400430514807
1142,yamadakkawanomzenykanekommiyazakiktsubotak,1,0.0004631773969430292,7.040536390215956,-7.677400430514807
1143,eguchiktomodaksawakitkawanamittanakamfukushimat,1,0.0004631773969430292,7.04141166379481,-7.677400430514807
1144,acknowledgment,1,0.0004631773969430292,7.042286171939743,-7.677400430514807
1145,sugaisumeharahproposalforanewclinicalentityigg4-positive,1,0.0004631773969430292,7.0431599159883405,-7.677400430514807
1146,thank,1,0.0004631773969430292,7.044032897274685,-7.677400430514807
1147,karine,1,0.0004631773969430292,7.044905117129371,-7.677400430514807
1148,barrau-baumstark,1,0.0004631773969430292,7.045776576879511,-7.677400430514807
1149,herassistance,1,0.0004631773969430292,7.046647277848756,-7.677400430514807
1150,multiorganlymphoproliferativesyndromeanalysisof64casesof,1,0.0004631773969430292,7.047517221357296,-7.677400430514807
1151,thestatisticalanalysis,1,0.0004631773969430292,7.048386408721883,-7.677400430514807
1152,igg4-relateddisordersannrheumdis2009681310y1315,1,0.0004631773969430292,7.049254841255837,-7.677400430514807
1153,okazakikkawaskamisawatnarusestanakasnishimorii,1,0.0004631773969430292,7.050122520269059,-7.677400430514807
1154,oharahitotkiriyamasinuikshimosegawatkoizumim,1,0.0004631773969430292,7.050989447068045,-7.677400430514807
1155,references,1,0.0004631773969430292,7.051855622955894,-7.677400430514807
1156,sudakshiratorikyamaguchikyamaguchitsugiyamam,1,0.0004631773969430292,7.052721049232323,-7.677400430514807
1157,aalbersercdiegesphknul-bretlovavvoorenpaalbersm,1,0.0004631773969430292,7.053585727193677,-7.677400430514807
1158,otsukimclinicaldiagnosticcriteriaofautoimmunepancreatitis,1,0.0004631773969430292,7.05444965813294,-7.677400430514807
1159,vanleeuwenjigg4asablockingantibodyclinrevallergy,1,0.0004631773969430292,7.055312843339752,-7.677400430514807
1160,revisedproposaljgastroenterol200641626y631,1,0.0004631773969430292,7.05617528410041,-7.677400430514807
1161,19831289y302,1,0.0004631773969430292,7.057036981697891,-7.677400430514807
1162,okazakikuchidakkoyabummiyoshihtakaokamrecent,1,0.0004631773969430292,7.057897937411856,-7.677400430514807
1163,aalbersercstapelsoschuurmanjrispenstimmunoglobuling4,1,0.0004631773969430292,7.0587581525186645,-7.677400430514807
1164,advancesintheconceptanddiagnosisofautoimmunepancreatitisand,1,0.0004631773969430292,7.059617628291383,-7.677400430514807
1165,anoddantibodyclinexpallergy200939469y477,1,0.0004631773969430292,7.060476365999801,-7.677400430514807
1166,igg4-relateddiseasejgastroenterol201146277y288,1,0.0004631773969430292,7.061334366910438,-7.677400430514807
1167,akitakerwatanabetzaimacuzanidahtadasnishidan,1,0.0004631773969430292,7.062191632286556,-7.677400430514807
1168,otsukimchungjbokazakikkimmhkamisawatkawas,1,0.0004631773969430292,7.0630481633881725,-7.677400430514807
1169,chibatpossibleinvolvementofthelpertype2responsestotoll-like,1,0.0004631773969430292,7.063903961472068,-7.677400430514807
1170,parkswshimosegawatleekitotnishimoriinotoharak,1,0.0004631773969430292,7.064759027791802,-7.677400430514807
1171,receptorligandsinigg4-relatedsclerosingdisease,1,0.0004631773969430292,7.065613363597717,-7.677400430514807
1172,naruseskosbkiharayasiandiagnosticcriteriaforautoimmune,1,0.0004631773969430292,7.066466970136958,-7.677400430514807
1173,gut201059542y545,1,0.0004631773969430292,7.067319848653476,-7.677400430514807
1174,pancreatitisconsensusofthejapan-koreasymposiumonautoimmune,1,0.0004631773969430292,7.068172000388042,-7.677400430514807
1175,pancreatitisjgastroenterol200843403y408,1,0.0004631773969430292,7.069023426578259,-7.677400430514807
1176,boulangerefuentesvmeigninvmougenotblabaumes,1,0.0004631773969430292,7.069874128458572,-7.677400430514807
1177,gouilleux-gruartvcognemaucouturierpclauveljproncop,1,0.0004631773969430292,7.0707241072602764,-7.677400430514807
1178,saekitnishisimainitotyamazakihkawanomyamamotom,1,0.0004631773969430292,7.071573364211532,-7.677400430514807
1179,lassouedkpolyclonaligg4hypergammaglobulinemiaassociated,1,0.0004631773969430292,7.072421900537371,-7.677400430514807
1180,takahashihmatsuisnakadasoriguchithirabayashia,1,0.0004631773969430292,7.07326971745971,-7.677400430514807
1181,withplasmacyticlymphadenopathyanemiaandnephropathy,1,0.0004631773969430292,7.074116816197362,-7.677400430514807
1182,hommantsubataytakatatwadaysaitoafukasesishiokak,1,0.0004631773969430292,7.074963197966044,-7.677400430514807
1183,annhematol200685833y840,1,0.0004631773969430292,7.075808863978387,-7.677400430514807
1184,miyazakikmasakiyumeharahsugaisnaritai,1,0.0004631773969430292,7.076653815443951,-7.677400430514807
1185,clinicopathologicalcharacteristicsofpatientswithigg4-related,1,0.0004631773969430292,7.077498053569231,-7.677400430514807
1186,cheukwyuenhkchusychiueklamlkchanjk,1,0.0004631773969430292,7.078341579557671,-7.677400430514807
1187,tubulointerstitialnephritiskidneyint2010781016y1023,1,0.0004631773969430292,7.079184394609668,-7.677400430514807
1188,lymphadenopathyofigg4-relatedsclerosingdisease,1,0.0004631773969430292,7.080026499922591,-7.677400430514807
1189,amjsurgpathol200832671y681,1,0.0004631773969430292,7.080867896690782,-7.677400430514807
1190,sarleshsarlesjcmuratorerguiencchronicinflammatory,1,0.0004631773969430292,7.081708586105575,-7.677400430514807
1191,sclerosisofthepancreasvanautonomouspancreaticdisease,1,0.0004631773969430292,7.0825485693553,-7.677400430514807
1192,choiekkimmhleetykwonsohhchwangcyseodw,1,0.0004631773969430292,7.083387847625295,-7.677400430514807
1193,amjdigdis19616688y698,1,0.0004631773969430292,7.084226422097916,-7.677400430514807
1194,leessleeskthesensitivityandspecificityofserum,1,0.0004631773969430292,7.085064293952548,-7.677400430514807
1195,immunoglobulingandimmunoglobuling4levelsinthediagnosis,1,0.0004631773969430292,7.085901464365611,-7.677400430514807
1196,stonejhkhosroshahiadeshpandevstonejrigg4-related,1,0.0004631773969430292,7.086737934510577,-7.677400430514807
1197,ofautoimmunechronicpancreatitiskoreanexperience,1,0.0004631773969430292,7.087573705557973,-7.677400430514807
1198,systemicdiseaseaccountsforasignificantproportionofthoracic,1,0.0004631773969430292,7.088408778675395,-7.677400430514807
1199,pancreas200735156y161,1,0.0004631773969430292,7.089243155027514,-7.677400430514807
1200,lymphoplasmacyticaortitiscasesarthritiscarereshoboken,1,0.0004631773969430292,7.090076835776092,-7.677400430514807
1201,201062316y322,1,0.0004631773969430292,7.0909098220799835,-7.677400430514807
1202,ghazaleacharistsmyrktclevymjtopazianmdtakahashin,1,0.0004631773969430292,7.091742115095153,-7.677400430514807
1203,clainjepearsonrkpelaez-lunampetersenbtvegess,1,0.0004631773969430292,7.0925737159746784,-7.677400430514807
1204,stonejhkhosroshahiahilgenbergaspooneraisselbacherem,1,0.0004631773969430292,7.093404625868766,-7.677400430514807
1205,farnellmbvalueofserumigg4inthediagnosisofautoimmune,1,0.0004631773969430292,7.094234845924755,-7.677400430514807
1206,stonejrigg4-relatedsystemicdiseaseandlymphoplasmacytic,1,0.0004631773969430292,7.095064377287131,-7.677400430514807
1207,pancreatitisandindistinguishingitfrompancreaticcancer,1,0.0004631773969430292,7.095893221097532,-7.677400430514807
1208,aortitisarthritisrheum2009603139y3145,1,0.0004631773969430292,7.0967213784947605,-7.677400430514807
1209,amjgastroenterol20071021646y1653,1,0.0004631773969430292,7.097548850614793,-7.677400430514807
1210,vanderneutkolfschotenmschuurmanjlosenmbleekerwk,1,0.0004631773969430292,7.098375638590786,-7.677400430514807
1211,hamanohkawashoriuchiaunnohfuruyanakamatsut,1,0.0004631773969430292,7.099201743553092,-7.677400430514807
1212,martinez-martinezpvermeulenedenblekerthwiegmanl,1,0.0004631773969430292,7.10002716662926,-7.677400430514807
1213,fukushimamnikaidotnakayamakusudankiyosawak,1,0.0004631773969430292,7.10085190894405,-7.677400430514807
1214,vinktaardenladebaetsmhvandewinkeljgaalberserc,1,0.0004631773969430292,7.101675971619444,-7.677400430514807
1215,highserumigg4concentrationsinpatientswithsclerosingpancreatitis,1,0.0004631773969430292,7.102499355774649,-7.677400430514807
1216,parrenpwanti-inflammatoryactivityofhumanigg4antibodies,1,0.0004631773969430292,7.103322062526113,-7.677400430514807
1217,nengljmed2001344732y738,1,0.0004631773969430292,7.104144092987527,-7.677400430514807
1218,bydynamicfabarmexchangescience20073171554y1557,1,0.0004631773969430292,7.1049654482698426,-7.677400430514807
1219,kamisawatokamotoaigg4-relatedsclerosingdisease,1,0.0004631773969430292,7.105786129481271,-7.677400430514807
1220,zenyfujiitharadakkawanomyamadaktakahiram,1,0.0004631773969430292,7.106606137727303,-7.677400430514807
1221,worldjgastroenterol2008143948y3955,1,0.0004631773969430292,7.107425474110705,-7.677400430514807
1222,nakanumayth2andregulatoryimmunereactionsareincreasedin,1,0.0004631773969430292,7.108244139731541,-7.677400430514807
1223,immunoglobing4-relatedsclerosingpancreatitisandcholangitis,1,0.0004631773969430292,7.109062135687172,-7.677400430514807
1224,kasashimaszenykawashimaaendommatsumotoy,1,0.0004631773969430292,7.1098794630722715,-7.677400430514807
1225,hepatology2007451538y1546,1,0.0004631773969430292,7.110696122978827,-7.677400430514807
1226,kasashimafohtakehnakanumayaclinicopathologicstudy,1,0.0004631773969430292,7.111512116496157,-7.677400430514807
1227,ofimmunoglobuling4-relatedsclerosingdiseaseofthethoracicaorta,1,0.0004631773969430292,7.112327444710911,-7.677400430514807
1228,zenynakanumaypathogenesisofigg4-relateddisease,1,0.0004631773969430292,7.113142108707088,-7.677400430514807
1229,jvascsurg2010521587y1595,1,0.0004631773969430292,7.113956109566034,-7.677400430514807
1230,curropinrheumatol201123114y118,1,0.0004631773969430292,7.114769448366463,-7.677400430514807
1231,56,1,0.0004631773969430292,7.115582126184454,-7.677400430514807
